WO2020211088A1 - Traditional chinese medicine composition and use thereof - Google Patents

Traditional chinese medicine composition and use thereof Download PDF

Info

Publication number
WO2020211088A1
WO2020211088A1 PCT/CN2019/083519 CN2019083519W WO2020211088A1 WO 2020211088 A1 WO2020211088 A1 WO 2020211088A1 CN 2019083519 W CN2019083519 W CN 2019083519W WO 2020211088 A1 WO2020211088 A1 WO 2020211088A1
Authority
WO
WIPO (PCT)
Prior art keywords
chinese medicine
traditional chinese
medicine composition
ethanol
acid
Prior art date
Application number
PCT/CN2019/083519
Other languages
French (fr)
Chinese (zh)
Inventor
吴以岭
吴相君
贾振华
吴瑞
Original Assignee
石家庄以岭药业股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 石家庄以岭药业股份有限公司 filed Critical 石家庄以岭药业股份有限公司
Priority to PCT/CN2019/083519 priority Critical patent/WO2020211088A1/en
Publication of WO2020211088A1 publication Critical patent/WO2020211088A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534Mentha (mint)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/63Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A61K36/634Forsythia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/70Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/708Rheum (rhubarb)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736Prunus, e.g. plum, cherry, peach, apricot or almond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/78Saururaceae (Lizard's-tail family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/04Drugs for disorders of the respiratory system for throat disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses

Definitions

  • This application relates to the field of medicine, in particular to a traditional Chinese medicine composition and its preparation method and application.
  • Traditional Chinese medicine is the most important material means for preventing and curing diseases in Chinese medicine. Improving the therapeutic effect of Chinese medicine is the key to the therapeutic effect of Chinese medicine. Regarding the characteristics of multi-component and multi-target effects of traditional Chinese medicine, increasing the content of multiple iconic components of traditional Chinese medicine can improve the quality of traditional Chinese medicine.
  • a Chinese medicine composition which is made of the following mass parts of Chinese medicine raw materials: Forsythia (Fructus Forsythia) 200-300, Ephedrae (Herba Ephedrae) 60-100, Rheum (rheum) 40-60, Houttuyniae (Herba Houttuyniae) 200-300, Honeysuckle (Flos Lonicerae) 200-300, Radix Isatidis (Radix Isatidis) 200-300, Huoxiang (Herba Pogostemonis) 60-100, Mianmaguan Public (Rhizoma Dryopteris Crassirhizomae) 200-300, Rhodiola (Rhodiola rosea L.) 60-100, Menthol (menthol) 5-9, Bitter almond (Semen Armeniacae Amarum) 60-100, Licorice (Radix Glycyrr
  • the traditional Chinese medicine composition contains the following ingredients:
  • the application also provides the use of the traditional Chinese medicine composition in the preparation of medicines for the treatment of colds and upper respiratory tract infections.
  • One or more embodiments of the present application provide a traditional Chinese medicine composition, which is made of the following mass parts of traditional Chinese medicine raw materials: forsythia (Fructus Forsythia) 200-300, ephedra (Herba Ephedrae) 60-100, rhubarb (rheum) 40 -60, Herba Houttuyniae 200-300, Flos Lonicerae 200-300, Radix Isatidis 200-300, Herba Pogostemonis 60-100, Rhizoma Dryopteris Crassirhizomae ) 200-300, Rhodiola rosea L. 60-100, Menthol 5-9, Semen Armeniacae Amarum 60-100, Radix Glycyrrhizae 60-100, Gypsum )200-300;
  • the traditional Chinese medicine composition contains the following ingredients:
  • the traditional Chinese medicine composition contains the following ingredients: 0.4-0.9mg/g ephedrine hydrochloride and pseudoephedrine hydrochloride, 2.2-4.3mg/g amygdalin, 0.25- 0.75mg/g chrysophanol, 0.15-0.40mg/g emodin, 2.4-5.4mg/g chlorogenic acid, 1.4-2.7mg/g neochlorogenic acid, 1.6-3.4mg/g cryptochlorogen Acid, 2.0-5.5mg/g isoficrin A, 1.65-2.90mg/g 4,5-di-O-caffeoylquinic acid, 2.7-3.8mg/g quercetin, 1.4- 2.9mg/g glycyrrhizic acid and 2.5-3.4mg/g forsythin.
  • the content of ephedrine hydrochloride and pseudoephedrine hydrochloride contained in the traditional Chinese medicine composition is 0.4 mg/g, 0.5 mg/g, 0.6 mg/g, 0.7 mg/g, 0.8 mg/g Or 0.9mg/g.
  • the content of amygdalin contained in the traditional Chinese medicine composition is 2.2 mg/g, 2.5 mg/g, 3 mg/g, 3.5 mg/g, 4 mg/g or 4.3 mg/g .
  • the content of chrysophanol contained in the traditional Chinese medicine composition is 0.25 mg/g, 0.3 mg/g, 0.4 mg/g, 0.5 mg/g, 0.6 mg/g, 0.7 mg/g g or 0.75mg/g.
  • the content of emodin contained in the traditional Chinese medicine composition is 0.15 mg/g, 0.2 mg/g, 0.3 mg/g or 0.40 mg/g.
  • the content of chlorogenic acid contained in the traditional Chinese medicine composition is 2.4 mg/g, 3 mg/g, 4 mg/g, 5 mg/g or 5.4 mg/g.
  • the content of neochlorogenic acid contained in the traditional Chinese medicine composition is 1.4 mg/g, 1.6 mg/g, 1.8 mg/g, 2 mg/g, 2.5 mg/g, or 2.7 mg/g. g.
  • the content of cryptochlorogenic acid contained in the traditional Chinese medicine composition is 1.6 mg/g, 2 mg/g, 2.5 mg/g, 3 mg/g or 3.4 mg/g.
  • the content of isoficrin A contained in the traditional Chinese medicine composition is 2.0 mg/g, 2.5 mg/g, 4 mg/g, 4.5 mg/g, 5 mg/g or 5.5 mg/g.
  • the content of di-O-caffeoylquinic acid contained in the traditional Chinese medicine composition is 0.65mg/g, 0.8mg/g, 1mg/g, 1.5mg/g, 1.7mg /g, 1.8mg/g or 1.90mg/g.
  • the content of quercetin contained in the traditional Chinese medicine composition is 2.7 mg/g, 3 mg/g, 3.2 mg/g, 3.5 mg/g or 3.8 mg/g.
  • the content of glycyrrhizic acid contained in the traditional Chinese medicine composition is 1.4 mg/g, 1.8 mg/g, 2 mg/g, 2.2 mg/g, 2.5 mg/g or 2.9 mg/g .
  • the content of forsythin contained in the traditional Chinese medicine composition is 2.5 mg/g, 3 mg/g, 3.1 mg/g, 3.2 mg/g, 3.3 mg/g, or 3.4 mg/g. g.
  • the traditional Chinese medicine composition contains the following ingredients: 4.0-5.4 mg/g chlorogenic acid, 2.0-2.7 mg/g neochlorogenic acid, 2.5-3.4 mg /g of cryptochlorogenic acid, 3.5-5.5mg/g of isoforsythoside A, 2.0-2.90mg/g of 4,5-di-O-caffeoylquinic acid, 3.0-3.8mg/g Quercetin and 2.5-2.9mg/g glycyrrhizic acid.
  • the ephedra is roasted ephedra
  • the bitter almond is fried bitter almond
  • the ageratum is patchouli
  • the honeysuckle, gypsum, Radix isatidis, Mianma Guanzhong, licorice and Rhodiola are boiled together with 7-11 weight-volume water, add bitter almonds, decoct for 1-4 hours, and combine the obtained extract with the Agastache Mix the clear ointment and concentrate the resulting mixture into a clear ointment, add 95% ethanol to the clear ointment until the ethanol concentration is 60-80%, leave it for 12-24 hours, filter through a ceramic membrane to obtain the filtrate, and recover the ethanol to obtain the second Clear cream
  • the second clearing paste is mixed with the first clearing paste, the mixture is concentrated under reduced pressure to obtain a paste with a relative density of 1.15 to 1.20, and the paste is vacuum belt dried and crushed to an appropriate particle size , To obtain a dry paste powder, and add menthol and the Huoxiang volatile oil to the dry paste powder to obtain the traditional Chinese medicine composition.
  • forsythia, ephedra, houttuynia cordata and rhubarb are extracted together with 6-10 weight-volume 70% ethanol for 1-2 times, each for 1-2 hours.
  • honeysuckle, gypsum, Isatis indigotica, Mianma Guanzhong, licorice and Rhodiola rosea are boiled together with water at a weight-volume ratio of 7-11, bitter almonds are added, and decocted for 1-2 Seconds, for 1-2 hours each time, mix the obtained extract with the Huoxiang clear ointment and concentrate the resulting mixture into a clear ointment with a relative density of 1.10-1.15.
  • 95% ethanol is added to the clear ointment until the ethanol concentration is 70%, and it is left at room temperature for 12-24 hours.
  • One or more embodiments of this application provide a method for preparing the traditional Chinese medicine composition of this application.
  • Forsythia Fratus Forsythia 200-300, Ephedrae (Herba) 60-100, Rheum (rheum) 40-60, Houttuyniae (Herba Houttuyniae) 200-300, Honeysuckle (Flos Lonicerae) 200-300, Radix Isatidis 200-300, Huoxiang (Herba Pogostemonis) 60-100, Rhizoma Dryopteris Crassirhizomae 200-300, Rhodiola Rosea L.) 60 -100, menthol (menthol) 5-9, bitter almond (Semen Armeniacae Amarum) 60-100, licorice (Radix Glycyrrhizae) 60-100, gypsum (gypsum) 200-300;
  • the honeysuckle, gypsum, Radix isatidis, Mianma Guanzhong, licorice and Rhodiola are boiled together with 7-11 weight-volume water, add bitter almonds, decoct for 1-4 hours, and combine the obtained extract with the Agastache
  • the clear paste is mixed and the resulting mixture is concentrated into a clear paste, 95% ethanol is added to the clear paste until the ethanol concentration is 60-80%, and it is left at room temperature for 12-24 hours.
  • the filtrate is filtered through a ceramic membrane, and the ethanol is recovered to obtain the third Erqing cream
  • the second clearing paste is mixed with the first clearing paste, the mixture is concentrated under reduced pressure to obtain a paste with a relative density of 1.15 to 1.20, and the paste is vacuum-belt dried and crushed to obtain a dry paste powder , Adding menthol and the volatile oil of Huoxiang to the dry powder to obtain the traditional Chinese medicine composition.
  • forsythia, ephedra, houttuynia cordata and rhubarb are extracted together with 6-10 weight-volume 70% ethanol for 1-2 times, each for 1-2 hours.
  • honeysuckle, gypsum, Isatis indigotica, Mianma Guanzhong, licorice and Rhodiola rosea are boiled together with water at a weight-volume ratio of 7-11, bitter almonds are added, and decocted for 1-2 Seconds, for 1-2 hours each time, mix the obtained extract with the Huoxiang clear ointment and concentrate the resulting mixture into a clear ointment with a relative density of 1.10-1.15.
  • 95% ethanol is added to the clear ointment until the ethanol concentration is 70%, and it is left at room temperature for 12-24 hours.
  • One or more embodiments of the present application provide the use of the traditional Chinese medicine composition of the present application in the preparation of a medicine for the treatment of colds and upper respiratory tract infections.
  • the common cold is influenza and the upper respiratory tract infection is tonsil inflammation.
  • the weight-to-volume ratio represents the volume (L or mL) of the solvent used for extraction corresponding to the weight (Kg or g) of the medicinal material.
  • the traditional Chinese medicine composition in one or more embodiments of the present application is used to treat a cold or upper respiratory tract infection.
  • the traditional Chinese medicine composition in one or more embodiments of the present application is used to treat influenza or tonsil inflammation.
  • the second clear paste is obtained by filtering through a ceramic membrane.
  • ceramic membrane filtration can be carried out by standing at room temperature. Using ceramic membrane filtration, the impurity removal effect is better, the extraction liquid filtration effect is better, and the content of active ingredients is increased. Using it to filter the original liquid has better filtering effect and better impurity removal effect.
  • the paste is obtained by filtration under reduced pressure.
  • the temperature in the vacuum filtration process is reduced, the time is shortened, and the active ingredient is less damaged.
  • the vacuum belt drying temperature is low and the speed is high, so the effective ingredients can be protected well.
  • Fructus Forsythia is the dried fruit of Forsythia suspensa (Thunb.) Vahl, a plant of the family Oleaceae.
  • Ephedrae (Herba Ephedrae) is a dry grass stem of Ephedra sinica Stapf, Ephedra intermedia Schrenk et C.A. Mey. or Ephedra equiisetina Bge.
  • rheum is the dried root of Rheum palmatum L., Rheum tanguticum Maxim. ex Balf. or medicinal Rheum officinale Baill. rhizome.
  • Houttuyniae (Herba Houttuyniae) is the dry aerial part of Houttuynia cordata Thunb.
  • Flos Lonicerae is Lonicera japonica Thunb., Lonicera hypoglauca Miq., Lonicera confusa DC. or Hairy style.
  • Radix Isatidis is the dry root of Isatis indigotica Fort., a cruciferous plant.
  • Herba Pogostemonis is Pogostemon cablin (Blanco) Benth. or Agastache rugosa (Fisch.et Mey.) O. Ktze.) The dry aerial part.
  • Rhizoma Dryopteris Crassirhizomae is the dry rhizome and petiole residues of Dryopteris Crassirhizoma Nakai, a plant of the Dryopteris family.
  • Rhodiola rosea is the dry aerial part of Rhodiola saera (Prain) Fu, a plant of the genus Rhodiola of the Crassulaceae family.
  • menthol is an aromatic oil obtained by distillation of fresh stems and leaves of Mentha haplocalyx Briq.
  • bitter almond is a Rosaceae plant Prunus armeniaca L.var.ansu Maxim.
  • Siberian apricot Prunus sibirica L.
  • the dried mature seeds of Prunus mandshurica (Maxim.) Koehne or Prunus armeniaca L..
  • licorice is the dried root of the legume Glycyrrhiza uralensis Fisch., Glycyrrhiza inflata Bat. or Glycyrrhiza glabra L. of the leguminous family.
  • gypsum is a sulfate mineral anhydrite group gypsum, and the main component is hydrous calcium sulfate (CaSO 4 ⁇ 2H 2 O).
  • step 6 Dissolve the menthol and the patchouli volatile oil obtained in step 2 with an appropriate amount of ethanol and spray them into the dry particles obtained in step 5, mix them, and fill them into capsules to obtain capsules of traditional Chinese medicine composition.
  • step 6 Dissolve the menthol and the patchouli volatile oil obtained in step 2 with an appropriate amount of ethanol and spray them into the dry particles obtained in step 5, mix them, and fill them into capsules to obtain capsules of traditional Chinese medicine composition.
  • step 6 Dissolve the menthol and the patchouli volatile oil obtained in step 2 with an appropriate amount of ethanol and spray them into the dry particles obtained in step 5, mix them, and fill them into capsules to obtain capsules of traditional Chinese medicine composition.
  • step 6 Dissolve the menthol and the patchouli volatile oil obtained in step 2 with an appropriate amount of ethanol and spray them into the dry particles obtained in step 5, mix them, and fill them into capsules to obtain capsules of traditional Chinese medicine composition.
  • step 6 Dissolve the menthol and the patchouli volatile oil obtained in step 2 with an appropriate amount of ethanol and spray them into the dry particles obtained in step 5, mix them, and fill them into capsules to obtain capsules of traditional Chinese medicine composition.
  • step 6 Dissolve the menthol and the patchouli volatile oil obtained in step 2 with an appropriate amount of ethanol and spray them into the dry particles obtained in step 5, mix them, and fill them into capsules to obtain capsules of traditional Chinese medicine composition.
  • step 6 Dissolve the menthol and the patchouli volatile oil obtained in step 2 with an appropriate amount of ethanol and spray them into the dry particles obtained in step 5, mix them, and fill them into capsules to obtain capsules of traditional Chinese medicine composition.
  • step 6 Dissolve the menthol and the patchouli volatile oil obtained in step 2 with an appropriate amount of ethanol and spray them into the dry particles obtained in step 5, mix them, and fill them into capsules to obtain capsules of traditional Chinese medicine composition.
  • ephedrine hydrochloride and pseudoephedrine hydrochloride reference substance Take an appropriate amount of ephedrine hydrochloride and pseudoephedrine hydrochloride reference substance, accurately weigh it, add methanol-water (containing 0.092% phosphoric acid, 0.04% triethylamine and 0.02% di-n-butylamine) 10:90 to make 30 ⁇ g ephedrine hydrochloride per 1mL And 8 ⁇ g pseudoephedrine hydrochloride mixed solution, that is.
  • sample A group Taking cold, influenza and tonsillitis patients in the outpatient clinic of Yiling Hospital of Hebei province as the research object, they were randomly divided into sample A group and sample B group with 84 cases each by using the digital table method.
  • Sample group A 54 males and 30 females; aged 15-63 years old, with an average age of 37 years.
  • Sample group B 52 males and 32 females; age 13-64 years old, average age 38 years old.
  • the two groups of patients were given corresponding care and the doctor ordered to drink more water.
  • Patients in the sample group A were given sample A; patients in the sample B group were given sample B; both groups were treated for 7 consecutive days.
  • the scores of TCM syndromes, the time of medicine to relieve fever and the disappearance time of pus spots were recorded and compared before and after treatment. .
  • the onset time is the time required for the body temperature to decrease by 0.5°C after taking the medicine.
  • Antipyretic time is the time required for body temperature to drop to 37°C after taking the medicine.
  • the recovery time is the time required for the clinical symptoms to disappear completely after taking the medicine.
  • the sample B group has more clinical advantages than the sample A group, and the difference is statistically significant (P ⁇ 0.05).
  • the total effective rate of sample B group was significantly better than that of sample A group, and the difference was statistically significant (P ⁇ 0.05).

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

A traditional Chinese medicine composition, prepared from the following traditional Chinese medicine crude drugs in part by weight: 200-300 parts of fructus forsythia, 60-100 parts of herba ephedrae, 40-60 parts of rheum, 200-300 parts of herba houttuyniae, 200-300 parts of flos lonicerae, 200-300 parts of radix isatidis, 60-100 parts of herba pogostemonis, 200-300 parts of rhizoma dryopteris crassirhizomae, 60-100 parts of rhodiola rosea L., 5-9 parts of menthol, 60-100 parts of semen armeniacae amarum, 60-100 parts of radix glycyrrhizae, and 200-300 parts of gypsum. The traditional Chinese medicine composition comprises the following components: 0.4-0.9 mg/g of ephedrine hydrochloride and pseudoephedrine hydrochloride, 2.2-4.3 mg/g of amygdalin, 0.25-0.75 mg/g of chrysophanol, 0.15-0.40 mg/g of rheum emodin, 2.4-5.4 mg/g of chlorogenic acid, 1.4-2.7 mg/g of neochlorogenic acid, 1.6-3.4 mg/g of cryptochlorogenic acid, 2.0-5.5 mg/g of isopsythioside A, 1.65-2.90 mg/g of 4,5-di-o-caffeoylquinic acid, 2.7-3.8 mg/g of quercitrin, 1.4-2.9 mg/g of glycyrrhizic acid, and 2.5-3.4 mg/g of phillyrin. The traditional Chinese medicine composition has the effect of treating cold and upper respiratory infection.

Description

中药组合物及其用途Chinese medicine composition and its use 技术领域Technical field
本申请涉及医药领域,具体涉及中药组合物及其制备方法和用途。This application relates to the field of medicine, in particular to a traditional Chinese medicine composition and its preparation method and application.
背景技术Background technique
中药是中医防病治病的最重要物质手段,提高中药的治疗效果是中医发挥治疗作用的关键。对于中药作用多组分多靶点的特点,提高多个中药标志性成分含量能够全面提高中药质量,这也是中药领域需要解决的问题。Traditional Chinese medicine is the most important material means for preventing and curing diseases in Chinese medicine. Improving the therapeutic effect of Chinese medicine is the key to the therapeutic effect of Chinese medicine. Regarding the characteristics of multi-component and multi-target effects of traditional Chinese medicine, increasing the content of multiple iconic components of traditional Chinese medicine can improve the quality of traditional Chinese medicine.
发明内容Summary of the invention
针对上述技术问题,本申请的一个或多个实施方式提供了中药组合物,其由以下质量份的中药原料制成:连翘(Fructus Forsythia)200-300、麻黄(Herba Ephedrae)60-100、大黄(rheum)40-60、鱼腥草(Herba Houttuyniae)200-300、金银花(Flos Lonicerae)200-300、板蓝根(Radix Isatidis)200-300、藿香(Herba Pogostemonis)60-100、绵马贯众(Rhizoma Dryopteris Crassirhizomae)200-300、红景天(Rhodiola rosea L.)60-100、薄荷脑(menthol)5-9、苦杏仁(Semen Armeniacae Amarum)60-100、甘草(Radix Glycyrrhizae)60-100、石膏(gypsum)200-300;In response to the above technical problems, one or more embodiments of the present application provide a Chinese medicine composition, which is made of the following mass parts of Chinese medicine raw materials: Forsythia (Fructus Forsythia) 200-300, Ephedrae (Herba Ephedrae) 60-100, Rheum (rheum) 40-60, Houttuyniae (Herba Houttuyniae) 200-300, Honeysuckle (Flos Lonicerae) 200-300, Radix Isatidis (Radix Isatidis) 200-300, Huoxiang (Herba Pogostemonis) 60-100, Mianmaguan Public (Rhizoma Dryopteris Crassirhizomae) 200-300, Rhodiola (Rhodiola rosea L.) 60-100, Menthol (menthol) 5-9, Bitter almond (Semen Armeniacae Amarum) 60-100, Licorice (Radix Glycyrrhizae) 60- 100. Gypsum (gypsum) 200-300;
所述中药组合物包含以下含量的成分:The traditional Chinese medicine composition contains the following ingredients:
0.4-0.9mg/g的盐酸麻黄碱和盐酸伪麻黄碱、2.2-4.3mg/g的苦杏仁苷、0.25-0.75mg/g的大黄酚、0.15-0.40mg/g的大黄素、2.4-5.4mg/g的绿原酸、1.4-2.7mg/g的新绿原酸、1.6-3.4mg/g的隐绿原酸、2.0-5.5mg/g的异连翘酯苷A、1.65-2.90mg/g的4,5-二-O-咖啡酰奎宁酸、2.7-3.8mg/g的槲皮苷、1.4-2.9mg/g的甘草酸和2.5-3.4mg/g的连翘苷。0.4-0.9mg/g ephedrine hydrochloride and pseudoephedrine hydrochloride, 2.2-4.3mg/g amygdalin, 0.25-0.75mg/g chrysophanol, 0.15-0.40mg/g emodin, 2.4-5.4mg/ g of chlorogenic acid, 1.4-2.7mg/g of neochlorogenic acid, 1.6-3.4mg/g of cryptochlorogenic acid, 2.0-5.5mg/g of isoforsythoside A, 1.65-2.90mg/g 4,5-Di-O-caffeoylquinic acid, quercetin at 2.7-3.8mg/g, glycyrrhizin at 1.4-2.9mg/g and forsythin at 2.5-3.4mg/g.
本申请还提供了中药组合物在制备用于治疗感冒和上呼吸道感染的药物中的用途。The application also provides the use of the traditional Chinese medicine composition in the preparation of medicines for the treatment of colds and upper respiratory tract infections.
发明详述Detailed description of the invention
本申请的一个或多个实施方式提供了中药组合物,其由以下质量份的中药原料制成:连翘(Fructus Forsythia)200-300、麻黄(Herba Ephedrae)60-100、大黄(rheum)40-60、鱼腥草(Herba Houttuyniae)200-300、金银花(Flos Lonicerae)200-300、板蓝根(Radix Isatidis)200-300、藿香(Herba Pogostemonis)60-100、绵马贯众(Rhizoma Dryopteris Crassirhizomae)200-300、红景天(Rhodiola rosea L.)60-100、薄荷脑(menthol)5-9、苦杏仁(Semen Armeniacae Amarum)60-100、甘草(Radix Glycyrrhizae)60-100、石膏(gypsum)200-300;One or more embodiments of the present application provide a traditional Chinese medicine composition, which is made of the following mass parts of traditional Chinese medicine raw materials: forsythia (Fructus Forsythia) 200-300, ephedra (Herba Ephedrae) 60-100, rhubarb (rheum) 40 -60, Herba Houttuyniae 200-300, Flos Lonicerae 200-300, Radix Isatidis 200-300, Herba Pogostemonis 60-100, Rhizoma Dryopteris Crassirhizomae ) 200-300, Rhodiola rosea L. 60-100, Menthol 5-9, Semen Armeniacae Amarum 60-100, Radix Glycyrrhizae 60-100, Gypsum )200-300;
所述中药组合物包含以下含量的成分:The traditional Chinese medicine composition contains the following ingredients:
0.4-0.9mg/g的盐酸麻黄碱和盐酸伪麻黄碱、2.2-4.3mg/g的苦杏仁苷、0.25-0.75mg/g的大黄酚、0.15-0.40mg/g的大黄素、2.4-5.4mg/g的绿原酸、1.4-2.7mg/g的新绿原酸、1.6-3.4mg/g的隐绿原酸、2.0-5.5mg/g的异连翘酯苷A、1.65-2.90mg/g的4,5-二-O-咖啡酰奎宁酸、2.7-3.8mg/g的槲皮苷、1.4-2.9mg/g的甘草酸和2.5-3.4mg/g的连翘苷。0.4-0.9mg/g ephedrine hydrochloride and pseudoephedrine hydrochloride, 2.2-4.3mg/g amygdalin, 0.25-0.75mg/g chrysophanol, 0.15-0.40mg/g emodin, 2.4-5.4mg/ g of chlorogenic acid, 1.4-2.7mg/g of neochlorogenic acid, 1.6-3.4mg/g of cryptochlorogenic acid, 2.0-5.5mg/g of isoforsythoside A, 1.65-2.90mg/g 4,5-Di-O-caffeoylquinic acid, quercetin at 2.7-3.8mg/g, glycyrrhizin at 1.4-2.9mg/g and forsythin at 2.5-3.4mg/g.
在本申请的一个或多个实施方式中,所述中药组合物包含以下含量的成分:0.4-0.9mg/g的盐酸麻黄碱和盐酸伪麻黄碱、2.2-4.3mg/g的苦杏仁苷、0.25-0.75mg/g的大黄酚、0.15-0.40mg/g的大黄素、2.4-5.4mg/g的绿原酸、1.4-2.7mg/g的新绿原酸、1.6-3.4mg/g的隐绿原酸、2.0-5.5mg/g的异连翘酯苷A、1.65-2.90mg/g的4,5-二-O-咖啡酰奎宁酸、2.7-3.8mg/g的槲皮苷、1.4-2.9mg/g的甘草酸和2.5-3.4mg/g的连翘苷。In one or more embodiments of the present application, the traditional Chinese medicine composition contains the following ingredients: 0.4-0.9mg/g ephedrine hydrochloride and pseudoephedrine hydrochloride, 2.2-4.3mg/g amygdalin, 0.25- 0.75mg/g chrysophanol, 0.15-0.40mg/g emodin, 2.4-5.4mg/g chlorogenic acid, 1.4-2.7mg/g neochlorogenic acid, 1.6-3.4mg/g cryptochlorogen Acid, 2.0-5.5mg/g isoficrin A, 1.65-2.90mg/g 4,5-di-O-caffeoylquinic acid, 2.7-3.8mg/g quercetin, 1.4- 2.9mg/g glycyrrhizic acid and 2.5-3.4mg/g forsythin.
在本申请的一个或多个实施方式中,中药组合物包含的盐酸麻黄碱和盐酸伪麻黄碱的含量为0.4mg/g、0.5mg/g、0.6mg/g、0.7mg/g、0.8mg/g或0.9mg/g。In one or more embodiments of the present application, the content of ephedrine hydrochloride and pseudoephedrine hydrochloride contained in the traditional Chinese medicine composition is 0.4 mg/g, 0.5 mg/g, 0.6 mg/g, 0.7 mg/g, 0.8 mg/g Or 0.9mg/g.
在本申请的一个或多个实施方式中,中药组合物包含的苦杏仁苷的含量为2.2mg/g、2.5mg/g、3mg/g、3.5mg/g、4mg/g或4.3mg/g。In one or more embodiments of the present application, the content of amygdalin contained in the traditional Chinese medicine composition is 2.2 mg/g, 2.5 mg/g, 3 mg/g, 3.5 mg/g, 4 mg/g or 4.3 mg/g .
在本申请的一个或多个实施方式中,中药组合物包含的大黄酚的含量为0.25mg/g、0.3mg/g、0.4mg/g、0.5mg/g、0.6mg/g、0.7mg/g或0.75mg/g。In one or more embodiments of the present application, the content of chrysophanol contained in the traditional Chinese medicine composition is 0.25 mg/g, 0.3 mg/g, 0.4 mg/g, 0.5 mg/g, 0.6 mg/g, 0.7 mg/g g or 0.75mg/g.
在本申请的一个或多个实施方式中,中药组合物包含的大黄素的含量为0.15mg/g、0.2mg/g、0.3mg/g或0.40mg/g。In one or more embodiments of the present application, the content of emodin contained in the traditional Chinese medicine composition is 0.15 mg/g, 0.2 mg/g, 0.3 mg/g or 0.40 mg/g.
在本申请的一个或多个实施方式中,中药组合物包含的绿原酸的含量为 2.4mg/g、3mg/g、4mg/g、5mg/g或5.4mg/g。In one or more embodiments of the present application, the content of chlorogenic acid contained in the traditional Chinese medicine composition is 2.4 mg/g, 3 mg/g, 4 mg/g, 5 mg/g or 5.4 mg/g.
在本申请的一个或多个实施方式中,中药组合物包含的新绿原酸的含量为1.4mg/g、1.6mg/g、1.8mg/g、2mg/g、2.5mg/g或2.7mg/g。In one or more embodiments of the present application, the content of neochlorogenic acid contained in the traditional Chinese medicine composition is 1.4 mg/g, 1.6 mg/g, 1.8 mg/g, 2 mg/g, 2.5 mg/g, or 2.7 mg/g. g.
在本申请的一个或多个实施方式中,中药组合物包含的隐绿原酸的含量为1.6mg/g、2mg/g、2.5mg/g、3mg/g或3.4mg/g。In one or more embodiments of the present application, the content of cryptochlorogenic acid contained in the traditional Chinese medicine composition is 1.6 mg/g, 2 mg/g, 2.5 mg/g, 3 mg/g or 3.4 mg/g.
在本申请的一个或多个实施方式中,中药组合物包含的异连翘酯苷A的含量为2.0mg/g、2.5mg/g、4mg/g、4.5mg/g、5mg/g或5.5mg/g。In one or more embodiments of the present application, the content of isoficrin A contained in the traditional Chinese medicine composition is 2.0 mg/g, 2.5 mg/g, 4 mg/g, 4.5 mg/g, 5 mg/g or 5.5 mg/g.
在本申请的一个或多个实施方式中,中药组合物包含的二-O-咖啡酰奎宁酸的含量为0.65mg/g、0.8mg/g、1mg/g、1.5mg/g、1.7mg/g、1.8mg/g或1.90mg/g。In one or more embodiments of the present application, the content of di-O-caffeoylquinic acid contained in the traditional Chinese medicine composition is 0.65mg/g, 0.8mg/g, 1mg/g, 1.5mg/g, 1.7mg /g, 1.8mg/g or 1.90mg/g.
在本申请的一个或多个实施方式中,中药组合物包含的槲皮苷的含量为2.7mg/g、3mg/g、3.2mg/g、3.5mg/g或3.8mg/g。In one or more embodiments of the present application, the content of quercetin contained in the traditional Chinese medicine composition is 2.7 mg/g, 3 mg/g, 3.2 mg/g, 3.5 mg/g or 3.8 mg/g.
在本申请的一个或多个实施方式中,中药组合物包含的甘草酸的含量为1.4mg/g、1.8mg/g、2mg/g、2.2mg/g、2.5mg/g或2.9mg/g。In one or more embodiments of the present application, the content of glycyrrhizic acid contained in the traditional Chinese medicine composition is 1.4 mg/g, 1.8 mg/g, 2 mg/g, 2.2 mg/g, 2.5 mg/g or 2.9 mg/g .
在本申请的一个或多个实施方式中,中药组合物包含的连翘苷的含量为2.5mg/g、3mg/g、3.1mg/g、3.2mg/g、3.3mg/g或3.4mg/g。In one or more embodiments of the present application, the content of forsythin contained in the traditional Chinese medicine composition is 2.5 mg/g, 3 mg/g, 3.1 mg/g, 3.2 mg/g, 3.3 mg/g, or 3.4 mg/g. g.
在本申请的一个或多个实施方式中,其中所述中药组合物包含以下含量的成分:4.0-5.4mg/g的绿原酸、2.0-2.7mg/g的新绿原酸、2.5-3.4mg/g的隐绿原酸、3.5-5.5mg/g的异连翘酯苷A、2.0-2.90mg/g的4,5-二-O-咖啡酰奎宁酸、3.0-3.8mg/g的槲皮苷和2.5-2.9mg/g的甘草酸。In one or more embodiments of the present application, the traditional Chinese medicine composition contains the following ingredients: 4.0-5.4 mg/g chlorogenic acid, 2.0-2.7 mg/g neochlorogenic acid, 2.5-3.4 mg /g of cryptochlorogenic acid, 3.5-5.5mg/g of isoforsythoside A, 2.0-2.90mg/g of 4,5-di-O-caffeoylquinic acid, 3.0-3.8mg/g Quercetin and 2.5-2.9mg/g glycyrrhizic acid.
在本申请的一个或多个实施方式中,其中所述麻黄为炙麻黄,所述苦杏仁为炒苦杏仁,所述藿香为广藿香。In one or more embodiments of the present application, wherein the ephedra is roasted ephedra, the bitter almond is fried bitter almond, and the ageratum is patchouli.
在本申请的一个或多个实施方式中,其中所述中药组合物通过如下方法制备:In one or more embodiments of the present application, wherein the traditional Chinese medicine composition is prepared by the following method:
按照上述质量比称取所述中药原料;Weigh the raw materials of Chinese medicine according to the above-mentioned mass ratio;
将藿香用8-10重量体积比的水提取2-4小时,获得藿香挥发油和藿香清膏;Extract Huoxiang with 8-10 weight-volume water for 2-4 hours to obtain Huoxiang volatile oil and Huoxiang cream;
将连翘、麻黄、鱼腥草和大黄一并用6-10重量体积比的50-90%的乙醇提取,回收乙醇得到第一清膏;Extract forsythia, ephedra, houttuynia cordata and rhubarb together with 50-90% ethanol at a weight-volume ratio of 6-10, and recover the ethanol to obtain the first clear ointment;
将金银花、石膏、板蓝根、绵马贯众、甘草和红景天一并用7-11重量体积 比的水煮沸,加入苦杏仁,煎煮1-4小时,将获得的提取液与所述藿香清膏混合并将所得的混合物浓缩成清膏,向所述清膏加入95%的乙醇直至乙醇浓度为60-80%,放置12-24小时,经陶瓷膜过滤获得滤液,回收乙醇得到第二清膏;The honeysuckle, gypsum, Radix isatidis, Mianma Guanzhong, licorice and Rhodiola are boiled together with 7-11 weight-volume water, add bitter almonds, decoct for 1-4 hours, and combine the obtained extract with the Agastache Mix the clear ointment and concentrate the resulting mixture into a clear ointment, add 95% ethanol to the clear ointment until the ethanol concentration is 60-80%, leave it for 12-24 hours, filter through a ceramic membrane to obtain the filtrate, and recover the ethanol to obtain the second Clear cream
将所述第二清膏与所述第一提清膏混合,将混合物减压浓缩得到相对密度1.15-1.20的膏状物,将所述膏状物进行真空带式干燥并粉碎至适当粒径,得到干膏粉,向所述干膏粉加入薄荷脑和所述藿香挥发油从而获得所述中药组合物。The second clearing paste is mixed with the first clearing paste, the mixture is concentrated under reduced pressure to obtain a paste with a relative density of 1.15 to 1.20, and the paste is vacuum belt dried and crushed to an appropriate particle size , To obtain a dry paste powder, and add menthol and the Huoxiang volatile oil to the dry paste powder to obtain the traditional Chinese medicine composition.
在本申请的一个或多个实施方式中,其中向所述干膏粉加入85%乙醇,制成颗粒,干燥得干颗粒;向所述干颗粒加入所述薄荷脑、所述藿香挥发油,混匀后装入胶囊,得到中药组合物胶囊剂。In one or more embodiments of the present application, wherein 85% ethanol is added to the dry paste powder to form granules, which are dried to obtain dry granules; the menthol and the Huoxiang volatile oil are added to the dry granules, After mixing, the capsules are filled to obtain the traditional Chinese medicine composition capsules.
在本申请的一个或多个实施方式中,其中将连翘、麻黄、鱼腥草和大黄一并用6-10重量体积比的70%的乙醇提取1-2次,每次1-2小时。In one or more embodiments of the present application, forsythia, ephedra, houttuynia cordata and rhubarb are extracted together with 6-10 weight-volume 70% ethanol for 1-2 times, each for 1-2 hours.
在本申请的一个或多个实施方式中,将金银花、石膏、板蓝根、绵马贯众、甘草和红景天一并用7-11重量体积比的水煮沸,加入苦杏仁,煎煮1-2次,每次1-2小时,将获得的提取液与所述藿香清膏混合并将所得的混合物浓缩成相对密度为1.10-1.15的清膏。In one or more embodiments of the present application, honeysuckle, gypsum, Isatis indigotica, Mianma Guanzhong, licorice and Rhodiola rosea are boiled together with water at a weight-volume ratio of 7-11, bitter almonds are added, and decocted for 1-2 Seconds, for 1-2 hours each time, mix the obtained extract with the Huoxiang clear ointment and concentrate the resulting mixture into a clear ointment with a relative density of 1.10-1.15.
在本申请的一个或多个实施方式中,其中向所述清膏加入95%的乙醇直至乙醇浓度为70%,室温放置12-24小时。In one or more embodiments of the present application, 95% ethanol is added to the clear ointment until the ethanol concentration is 70%, and it is left at room temperature for 12-24 hours.
本申请的一个或多个实施方式提供了本申请的中药组合物的制备方法。One or more embodiments of this application provide a method for preparing the traditional Chinese medicine composition of this application.
按照以下质量比称取所述中药原料:连翘(Fructus Forsythia)200-300、麻黄(Herba Ephedrae)60-100、大黄(rheum)40-60、鱼腥草(Herba Houttuyniae)200-300、金银花(Flos Lonicerae)200-300、板蓝根(Radix Isatidis)200-300、藿香(Herba Pogostemonis)60-100、绵马贯众(Rhizoma Dryopteris Crassirhizomae)200-300、红景天(Rhodiola rosea L.)60-100、薄荷脑(menthol)5-9、苦杏仁(Semen Armeniacae Amarum)60-100、甘草(Radix Glycyrrhizae)60-100、石膏(gypsum)200-300;Weigh the raw materials of Chinese medicine according to the following mass ratios: Forsythia (Fructus Forsythia) 200-300, Ephedrae (Herba) 60-100, Rheum (rheum) 40-60, Houttuyniae (Herba Houttuyniae) 200-300, Honeysuckle (Flos Lonicerae) 200-300, Radix Isatidis 200-300, Huoxiang (Herba Pogostemonis) 60-100, Rhizoma Dryopteris Crassirhizomae 200-300, Rhodiola Rosea L.) 60 -100, menthol (menthol) 5-9, bitter almond (Semen Armeniacae Amarum) 60-100, licorice (Radix Glycyrrhizae) 60-100, gypsum (gypsum) 200-300;
将藿香用8-10重量体积比的水提取2-4小时,获得藿香挥发油和藿香清膏;Extract Huoxiang with 8-10 weight-volume water for 2-4 hours to obtain Huoxiang volatile oil and Huoxiang cream;
将连翘、麻黄、鱼腥草和大黄一并用6-10重量体积比的50-90%的乙醇提取,回收乙醇得到第一清膏;Extract forsythia, ephedra, houttuynia cordata and rhubarb together with 50-90% ethanol at a weight-volume ratio of 6-10, and recover the ethanol to obtain the first clear ointment;
将金银花、石膏、板蓝根、绵马贯众、甘草和红景天一并用7-11重量体积比的水煮沸,加入苦杏仁,煎煮1-4小时,将获得的提取液与所述藿香清膏混合并将所得的混合物浓缩成清膏,向所述清膏加入95%的乙醇直至乙醇浓度为60-80%,室温放置12-24小时,经陶瓷膜过滤获得滤液,回收乙醇得到第二清膏;The honeysuckle, gypsum, Radix isatidis, Mianma Guanzhong, licorice and Rhodiola are boiled together with 7-11 weight-volume water, add bitter almonds, decoct for 1-4 hours, and combine the obtained extract with the Agastache The clear paste is mixed and the resulting mixture is concentrated into a clear paste, 95% ethanol is added to the clear paste until the ethanol concentration is 60-80%, and it is left at room temperature for 12-24 hours. The filtrate is filtered through a ceramic membrane, and the ethanol is recovered to obtain the third Erqing cream
将所述第二清膏与所述第一提清膏混合,将混合物减压浓缩得到相对密度1.15-1.20的膏状物,将所述膏状物进行真空带式干燥并粉碎得到干膏粉,向所述干膏粉加入薄荷脑和所述藿香挥发油从而获得所述中药组合物。The second clearing paste is mixed with the first clearing paste, the mixture is concentrated under reduced pressure to obtain a paste with a relative density of 1.15 to 1.20, and the paste is vacuum-belt dried and crushed to obtain a dry paste powder , Adding menthol and the volatile oil of Huoxiang to the dry powder to obtain the traditional Chinese medicine composition.
在本申请的一个或多个实施方式中,其中向所述干膏粉加入85%乙醇,制成颗粒,干燥得干颗粒;向所述干颗粒加入所述薄荷脑、所述藿香挥发油,混匀后装入胶囊,得到中药组合物胶囊剂。In one or more embodiments of the present application, wherein 85% ethanol is added to the dry paste powder to form granules, which are dried to obtain dry granules; the menthol and the Huoxiang volatile oil are added to the dry granules, After mixing, the capsules are filled to obtain the traditional Chinese medicine composition capsules.
在本申请的一个或多个实施方式中,其中将连翘、麻黄、鱼腥草和大黄一并用6-10重量体积比的70%的乙醇提取1-2次,每次1-2小时。In one or more embodiments of the present application, forsythia, ephedra, houttuynia cordata and rhubarb are extracted together with 6-10 weight-volume 70% ethanol for 1-2 times, each for 1-2 hours.
在本申请的一个或多个实施方式中,将金银花、石膏、板蓝根、绵马贯众、甘草和红景天一并用7-11重量体积比的水煮沸,加入苦杏仁,煎煮1-2次,每次1-2小时,将获得的提取液与所述藿香清膏混合并将所得的混合物浓缩成相对密度为1.10-1.15的清膏。In one or more embodiments of the present application, honeysuckle, gypsum, Isatis indigotica, Mianma Guanzhong, licorice and Rhodiola rosea are boiled together with water at a weight-volume ratio of 7-11, bitter almonds are added, and decocted for 1-2 Seconds, for 1-2 hours each time, mix the obtained extract with the Huoxiang clear ointment and concentrate the resulting mixture into a clear ointment with a relative density of 1.10-1.15.
在本申请的一个或多个实施方式中,其中向所述清膏加入95%的乙醇直至乙醇浓度为70%,室温放置12-24小时。In one or more embodiments of the present application, 95% ethanol is added to the clear ointment until the ethanol concentration is 70%, and it is left at room temperature for 12-24 hours.
本申请的一个或多个实施方式提供了本申请的中药组合物在制备用于治疗感冒和上呼吸道感染的药物中的用途。One or more embodiments of the present application provide the use of the traditional Chinese medicine composition of the present application in the preparation of a medicine for the treatment of colds and upper respiratory tract infections.
在本申请的一个或多个实施方式中,其中所述感冒为流行性感冒,所述上呼吸道感染为扁桃体炎症。In one or more embodiments of the present application, wherein the common cold is influenza and the upper respiratory tract infection is tonsil inflammation.
在本申请的一个或多个实施方式中,重量体积比(Kg/L或g/mL)表示与药材重量(Kg或g)相对应的提取所用溶剂的体积的量(L或mL)。In one or more embodiments of the present application, the weight-to-volume ratio (Kg/L or g/mL) represents the volume (L or mL) of the solvent used for extraction corresponding to the weight (Kg or g) of the medicinal material.
本申请的一个或多个实施方式中的中药组合物用于治疗感冒或上呼吸道感染。The traditional Chinese medicine composition in one or more embodiments of the present application is used to treat a cold or upper respiratory tract infection.
本申请的一个或多个实施方式中的中药组合物用于治疗流行性感冒或扁桃体炎症。The traditional Chinese medicine composition in one or more embodiments of the present application is used to treat influenza or tonsil inflammation.
在本申请的一个或多个实施方式中,通过陶瓷膜过滤来获得第二清膏。通常陶瓷膜过滤可采用室温静置的方式进行。采用陶瓷膜过滤,杂质去除效果更好,提取液过滤效果更好,提高了有效成分的含量。采用其进行原液过滤,过滤效果更好,杂质去除效果更好。In one or more embodiments of the present application, the second clear paste is obtained by filtering through a ceramic membrane. Generally, ceramic membrane filtration can be carried out by standing at room temperature. Using ceramic membrane filtration, the impurity removal effect is better, the extraction liquid filtration effect is better, and the content of active ingredients is increased. Using it to filter the original liquid has better filtering effect and better impurity removal effect.
在本申请的一个或多个实施方式中,将所述第二清膏与所述第一提清膏混合后,通过减压过滤得到膏状物。不限于任何理论的限制,减压过滤过程中的温度降低,时间缩短,对活性成分的破坏较少。In one or more embodiments of the present application, after mixing the second clearing cream and the first clearing cream, the paste is obtained by filtration under reduced pressure. Not limited to any theoretical limitation, the temperature in the vacuum filtration process is reduced, the time is shortened, and the active ingredient is less damaged.
在本申请的一个或多个实施方式中,真空带式干燥温度低并且速度快,因此能够有好地保护有效成分。In one or more embodiments of the present application, the vacuum belt drying temperature is low and the speed is high, so the effective ingredients can be protected well.
在本申请的一个或多个实施方式中,连翘(Fructus Forsythia)为为木犀科植物连翘Forsythia suspensa(Thunb.)Vahl的干燥果实。In one or more embodiments of the present application, Fructus Forsythia is the dried fruit of Forsythia suspensa (Thunb.) Vahl, a plant of the family Oleaceae.
在本申请的一个或多个实施方式中,麻黄(Herba Ephedrae)为麻黄科植物草麻黄Ephedra sinica Stapf、中麻黄Ephedra intermedia Schrenk et C.A.Mey.或木贼麻黄Ephedra equisetina Bge.的干燥草质茎。In one or more embodiments of this application, Ephedrae (Herba Ephedrae) is a dry grass stem of Ephedra sinica Stapf, Ephedra intermedia Schrenk et C.A. Mey. or Ephedra equiisetina Bge.
在本申请的一个或多个实施方式中,大黄(rheum)为蓼科植物掌叶大黄Rheum palmatum L.、唐古特大黄Rheum tanguticum Maxim.ex Balf.或药用大黄Rheum officinale Baill.的干燥根及根茎。In one or more embodiments of this application, rheum (rheum) is the dried root of Rheum palmatum L., Rheum tanguticum Maxim. ex Balf. or medicinal Rheum officinale Baill. rhizome.
在本申请的一个或多个实施方式中,鱼腥草(Herba Houttuyniae)为三白草科植物蕺菜Houttuynia cordata Thunb.的干燥地上部分。In one or more embodiments of the present application, Houttuyniae (Herba Houttuyniae) is the dry aerial part of Houttuynia cordata Thunb.
在本申请的一个或多个实施方式中,金银花(Flos Lonicerae)为忍冬科植物忍冬Lonicera japonica Thunb.、红腺忍冬Lonicera hypoglauca Miq.、山银花(毛萼忍冬)Lonicera confusa DC.或毛花柱忍冬Lonicera dasystyla Rehd.的干燥花蕾或带初开的花。In one or more embodiments of the present application, Flos Lonicerae is Lonicera japonica Thunb., Lonicera hypoglauca Miq., Lonicera confusa DC. or Hairy style. The dry buds of Lonicera dasystyla Rehd. or the first blooming flowers.
在本申请的一个或多个实施方式中,板蓝根(Radix Isatidis)为十字花科植物菘蓝Isatis indigotica Fort.的干燥根。In one or more embodiments of the present application, Radix Isatidis is the dry root of Isatis indigotica Fort., a cruciferous plant.
在本申请的一个或多个实施方式中,藿香(Herba Pogostemonis)为唇形科植物广藿香(Pogostemon cablin(Blanco)Benth.)或藿香(Agastache rugosa(Fisch.et Mey.)O.Ktze.)的干燥地上部分。In one or more embodiments of this application, Herba Pogostemonis is Pogostemon cablin (Blanco) Benth. or Agastache rugosa (Fisch.et Mey.) O. Ktze.) The dry aerial part.
在本申请的一个或多个实施方式中,绵马贯众(Rhizoma Dryopteris  Crassirhizomae)为鳞毛蕨科植物粗茎鳞毛蕨Dryopteris crassirhizoma Nakai的干燥根茎及叶柄残基。In one or more embodiments of the present application, Rhizoma Dryopteris Crassirhizomae is the dry rhizome and petiole residues of Dryopteris Crassirhizoma Nakai, a plant of the Dryopteris family.
在本申请的一个或多个实施方式中,红景天(Rhodiola rosea)为景天科红景天属植物红景天Rhodiola saera(Prain)Fu的干燥地上部分。In one or more embodiments of the present application, Rhodiola rosea is the dry aerial part of Rhodiola saera (Prain) Fu, a plant of the genus Rhodiola of the Crassulaceae family.
在本申请的一个或多个实施方式中,薄荷脑(menthol)为唇形科植物薄荷(Mentha haplocalyx Briq.)的鲜茎叶经蒸馏而得的芳香油。In one or more embodiments of the present application, menthol (menthol) is an aromatic oil obtained by distillation of fresh stems and leaves of Mentha haplocalyx Briq.
在本申请的一个或多个实施方式中,苦杏仁(Semen Armeniacae Amarum)为蔷薇科植物山杏(苦杏)Prunus armeniaca L.var.ansu Maxim.、西伯利亚杏(山杏)Prunus sibirica L.、东北杏Prunus mandshurica(Maxim.)Koehne或杏Prunus armeniaca L.的干燥成熟种子。In one or more embodiments of this application, bitter almond (Semen Armeniacae Amarum) is a Rosaceae plant Prunus armeniaca L.var.ansu Maxim., Siberian apricot (Mountain apricot) Prunus sibirica L., The dried mature seeds of Prunus mandshurica (Maxim.) Koehne or Prunus armeniaca L..
在本申请的一个或多个实施方式中,甘草(Radix Glycyrrhizae)为豆科植物甘草Glycyrrhiza uralensis Fisch.、胀果甘草Glycyrrhiza inflata Bat.或光果甘草Glycyrrhiza glabra L.的干燥根。In one or more embodiments of the present application, licorice (Radix Glycyrrhizae) is the dried root of the legume Glycyrrhiza uralensis Fisch., Glycyrrhiza inflata Bat. or Glycyrrhiza glabra L. of the leguminous family.
在本申请的一个或多个实施方式中,石膏(gypsum)为硫酸盐类矿物硬石膏族石膏,主要成分为含水硫酸钙(CaSO 4·2H 2O)。 In one or more embodiments of the present application, gypsum (gypsum) is a sulfate mineral anhydrite group gypsum, and the main component is hydrous calcium sulfate (CaSO 4 ·2H 2 O).
具体实施方式detailed description
制备实施例1Preparation Example 1
1、按照以下重量比例称取各净选的中药材:连翘200、金银花300、板蓝根200、大黄40、广藿香60、绵马贯众300、红景天100、薄荷脑9、麻黄60、苦杏仁100、鱼腥草200、甘草100、石膏200;1. Weigh the selected Chinese medicinal materials according to the following weight ratios: Forsythia 200, Honeysuckle 300, Isatis root 200, Rhubarb 40, Patchouli 60, Mianma Guanzhong 300, Rhodiola 100, Menthol 9, Ephedra 60 , Bitter Almond 100, Houttuynia Cordata 200, Licorice 100, Gypsum 200;
2、向广藿香加10重量体积比的水,煮沸提取挥发油,提取时间4小时,收集广藿香挥发油,将提取液过滤后得到广藿香清膏备用,残渣弃去;2. Add 10 weight-volume water to the patchouli, extract the volatile oil by boiling, extract the volatile oil for 4 hours, collect the patchouli volatile oil, filter the extract to obtain a patchouli cream for later use, and discard the residue;
3、将连翘、麻黄、鱼腥草和大黄用10重量体积比的90%的乙醇共提2次,第一次2小时,第二次1.5小时,提取液过滤,滤液合并,回收乙醇得到第一清膏备用;3. Extract forsythia, ephedra, houttuynia cordata and rhubarb with 90% ethanol at a ratio of 10 weight by volume for 2 times, the first time is 2 hours, the second time is 1.5 hours, the extract is filtered, the filtrates are combined, and the ethanol is recovered The first clear ointment is reserved;
4、向金银花、石膏、板蓝根、绵马贯众、甘草和红景天加11重量体积比的水煎煮至沸,加入苦杏仁,煎煮2次,第一次1.5小时,第二次1小时,将提取液过滤,将滤液加入步骤2所得的广藿香清膏,浓缩成相对密度为1.15 的清膏,加入95%乙醇,边加边搅拌,至醇浓度为70%,室温放置24小时,经陶瓷膜过滤、滤液回收乙醇至无醇味得到第二清膏,将第二清膏与步骤3所得的第一清膏合并,减压浓缩至相对密度1.20的膏状物,将该膏状物进行真空带式干燥,粉碎得干膏粉;4. Add 11 weight-volume water to honeysuckle, gypsum, Radix isatidis, Mianma Guanzhong, licorice and rhodiola, and boil until boiling, add bitter almonds, decoc 2 times, 1.5 hours for the first time, and 1 for the second time. After hours, the extract was filtered, and the filtrate was added to the patchouli clear ointment obtained in step 2, and concentrated into a clear ointment with a relative density of 1.15. 95% ethanol was added and stirred while adding until the alcohol concentration was 70%. After hours, the second clear ointment is obtained by filtering through a ceramic membrane and recovering ethanol from the filtrate until there is no alcohol flavor. The paste is vacuum belt-dried and crushed to obtain dry paste powder;
5、向干膏粉加入适量85%的乙醇制成颗粒,干燥得干颗粒;5. Add an appropriate amount of 85% ethanol to the dry paste powder to make granules, and dry them to obtain dry granules;
6、将薄荷脑和步骤2所得的广藿香挥发油用适量乙醇溶解后喷入步骤5所得的干颗粒,混匀,装入胶囊,得到中药组合物胶囊。6. Dissolve the menthol and the patchouli volatile oil obtained in step 2 with an appropriate amount of ethanol and spray them into the dry particles obtained in step 5, mix them, and fill them into capsules to obtain capsules of traditional Chinese medicine composition.
制备实施例2Preparation Example 2
1、按照以下重量比例称取各净选的中药材:连翘300、金银花200、板蓝根300、大黄60、广藿香100、绵马贯众200、红景天60、薄荷脑5、麻黄100、苦杏仁60、鱼腥草300、甘草60、石膏300;1. Weigh the selected Chinese medicinal materials according to the following weight ratios: Forsythia 300, Honeysuckle 200, Isatis root 300, Rhubarb 60, Patchouli 100, Mianma Guanzhong 200, Rhodiola 60, Menthol 5, Ephedra 100 , Bitter Almond 60, Houttuynia 300, Licorice 60, Gypsum 300;
2、向广藿香加8重量体积比的水,煮沸提取挥发油,提取时间4小时,收集广藿香挥发油,将提取液过滤后得到广藿香清膏备用,残渣弃去;2. Add 8 weight-volume water to the patchouli to extract the volatile oil, extract the volatile oil for 4 hours, collect the patchouli volatile oil, filter the extract to obtain a patchouli cream for later use, and discard the residue;
3、将连翘、麻黄、鱼腥草和大黄用6重量体积比的60%的乙醇共提2次,第一次2小时,第二次1.5小时,提取液过滤,滤液合并,回收乙醇得到第一清膏备用;3. Extract forsythia, ephedra, houttuynia cordata and rhubarb with 6 weight-volume 60% ethanol for 2 times, the first time is 2 hours, the second time is 1.5 hours, the extract is filtered, the filtrates are combined, and the ethanol is recovered The first clear ointment is reserved;
4、向金银花、石膏、板蓝根、绵马贯众、甘草和红景天加7重量体积比的水煎煮至沸,加入苦杏仁,煎煮2次,第一次1.5小时,第二次1小时,将提取液过滤,将滤液加入步骤2所得的广藿香清膏,浓缩成相对密度为1.10的清膏,加入95%乙醇,边加边搅拌,至醇浓度为70%,室温放置24小时,经陶瓷膜过滤、滤液回收乙醇至无醇味得到第二清膏,将第二清膏与步骤3所得的第一清膏合并,减压浓缩至相对密度1.15的膏状物,将该膏状物进行真空带式干燥,粉碎得干膏粉;4. Add 7 weight-volume water to honeysuckle, gypsum, Radix isatidis, Mianma Guanzhong, licorice and rhodiola, and boil until boiling, add bitter almonds, decoc 2 times, first 1.5 hours, second 1 After hours, filter the extract, add the filtrate to the patchouli cream obtained in step 2, and concentrate it into a cream with a relative density of 1.10. Add 95% ethanol and stir while adding until the alcohol concentration is 70%. Place at room temperature for 24 hours. After hours, the second clear ointment is obtained by filtering through a ceramic membrane and recovering ethanol from the filtrate until there is no alcohol smell. The second clearing ointment is combined with the first clearing ointment obtained in step 3, and concentrated under reduced pressure to a paste with a relative density of 1.15. The paste is vacuum belt-dried and crushed to obtain dry paste powder;
5、向干膏粉加入适量85%的乙醇制成颗粒,干燥得干颗粒;5. Add an appropriate amount of 85% ethanol to the dry paste powder to make granules, and dry them to obtain dry granules;
6、将薄荷脑和步骤2所得的广藿香挥发油用适量乙醇溶解后喷入步骤5所得的干颗粒,混匀,装入胶囊,得到中药组合物胶囊。6. Dissolve the menthol and the patchouli volatile oil obtained in step 2 with an appropriate amount of ethanol and spray them into the dry particles obtained in step 5, mix them, and fill them into capsules to obtain capsules of traditional Chinese medicine composition.
制备实施例3Preparation Example 3
1、按照以下重量比例称取各净选的中药材:连翘278、金银花294、板蓝根285、大黄55、广藿香95、绵马贯众290、红景天87、薄荷脑8.5、麻黄88、苦杏仁80、鱼腥草284、甘草95、石膏277;1. Weigh the selected Chinese medicinal materials according to the following weight ratio: Forsythia 278, Honeysuckle 294, Isatis root 285, Rhubarb 55, Patchouli 95, Mianma Guanzhong 290, Rhodiola 87, Menthol 8.5, Ephedra 88 , Bitter Almond 80, Houttuynia Cordata 284, Licorice 95, Gypsum 277;
2、向广藿香加9重量体积比的水,煮沸提取挥发油,提取时间4小时,收集广藿香挥发油,将提取液过滤后得到广藿香清膏备用,残渣弃去;2. Add 9 weight-volume water to the patchouli to extract the volatile oil, extract the volatile oil for 4 hours, collect the patchouli volatile oil, filter the extract to obtain a patchouli cream for later use, and discard the residue;
3、将连翘、麻黄、鱼腥草和大黄用6重量体积比的80%的乙醇共提2次,第一次2小时,第二次1.5小时,提取液过滤,滤液合并,回收乙醇得到第一清膏备用;3. Extract forsythia, ephedra, houttuynia cordata and rhubarb with 6 weight-volume 80% ethanol for 2 times, the first time is 2 hours, the second time is 1.5 hours, the extract is filtered, the filtrates are combined, and the ethanol is recovered The first clear ointment is reserved;
4、向金银花、石膏、板蓝根、绵马贯众、甘草和红景天加10重量体积比的水煎煮至沸,加入苦杏仁,煎煮2次,第一次1.5小时,第二次1小时,将提取液过滤,将滤液加入步骤2所得的广藿香清膏,浓缩成相对密度为1.10的清膏,加入95%乙醇,边加边搅拌,至醇浓度为70%,室温放置24小时,经陶瓷膜过滤、滤液回收乙醇至无醇味得到第二清膏,将第二清膏与步骤3所得的第一清膏合并,减压浓缩至相对密度1.15的膏状物,将该膏状物进行真空带式干燥,粉碎得干膏粉;4. Add 10 weight-volume water to honeysuckle, gypsum, Radix isatidis, Mianma Guanzhong, licorice and Rhodiola and boil until boiling, add bitter almonds, decoc 2 times, first 1.5 hours, second 1 After hours, filter the extract, add the filtrate to the patchouli cream obtained in step 2, and concentrate it into a cream with a relative density of 1.10. Add 95% ethanol and stir while adding until the alcohol concentration is 70%. Place at room temperature for 24 hours. After hours, the second clear ointment is obtained by filtering through a ceramic membrane and recovering ethanol from the filtrate until there is no alcohol smell. The second clearing ointment is combined with the first clearing ointment obtained in step 3, and concentrated under reduced pressure to a paste with a relative density of 1.15. The paste is vacuum belt-dried and crushed to obtain dry paste powder;
5、向干膏粉加入适量85%的乙醇制成颗粒,干燥得干颗粒;5. Add an appropriate amount of 85% ethanol to the dry paste powder to make granules, and dry them to obtain dry granules;
6、将薄荷脑和步骤2所得的广藿香挥发油用适量乙醇溶解后喷入步骤5所得的干颗粒,混匀,装入胶囊,得到中药组合物胶囊。6. Dissolve the menthol and the patchouli volatile oil obtained in step 2 with an appropriate amount of ethanol and spray them into the dry particles obtained in step 5, mix them, and fill them into capsules to obtain capsules of traditional Chinese medicine composition.
制备实施例4Preparation Example 4
1、按照以下重量比例称取各净选的中药材:连翘255、金银花255、板蓝根255、大黄51、广藿香85、绵马贯众255、红景天85、薄荷脑7.5、麻黄85、苦杏仁85、鱼腥草255、甘草85、石膏255;1. Weigh the selected Chinese herbal medicines according to the following weight ratios: Forsythia 255, Honeysuckle 255, Isatis root 255, Rhubarb 51, Patchouli 85, Mianma Guanzhong 255, Rhodiola 85, Menthol 7.5, Ephedra 85 , Bitter Almond 85, Houttuynia 255, Licorice 85, Gypsum 255;
2、向广藿香加9重量体积比的水,煮沸提取挥发油,提取时间4小时,收集广藿香挥发油,将提取液过滤后得到广藿香清膏备用,残渣弃去;2. Add 9 weight-volume water to the patchouli to extract the volatile oil, extract the volatile oil for 4 hours, collect the patchouli volatile oil, filter the extract to obtain a patchouli cream for later use, and discard the residue;
3、将连翘、麻黄、鱼腥草和大黄用6重量体积比的80%的乙醇共提2次,第一次2小时,第二次1.5小时,提取液过滤,滤液合并,回收乙醇得到第一清膏备用;3. Extract forsythia, ephedra, houttuynia cordata and rhubarb with 6 weight-volume 80% ethanol for 2 times, the first time is 2 hours, the second time is 1.5 hours, the extract is filtered, the filtrates are combined, and the ethanol is recovered The first clear ointment is reserved;
4、向金银花、石膏、板蓝根、绵马贯众、甘草和红景天加10重量体积 比的水煎煮至沸,加入苦杏仁,煎煮2次,第一次1.5小时,第二次1小时,将提取液过滤,将滤液加入步骤2所得的广藿香清膏,浓缩成相对密度为1.10的清膏,加入95%乙醇,边加边搅拌,至醇浓度为70%,室温放置24小时,经陶瓷膜过滤、滤液回收乙醇至无醇味得到第二清膏,将第二清膏与步骤3所得的第一清膏合并,减压浓缩至相对密度1.15的膏状物,将该膏状物进行真空带式干燥,粉碎得干膏粉;4. Add 10 weight-volume water to honeysuckle, gypsum, Radix isatidis, Mianma Guanzhong, licorice and Rhodiola and boil until boiling, add bitter almonds, decoc 2 times, first 1.5 hours, second 1 After hours, filter the extract, add the filtrate to the patchouli cream obtained in step 2, and concentrate it into a cream with a relative density of 1.10. Add 95% ethanol and stir while adding until the alcohol concentration is 70%. Place at room temperature for 24 hours. After hours, the second clear ointment is obtained by filtering through a ceramic membrane and recovering ethanol from the filtrate until there is no alcohol smell. The second clearing ointment is combined with the first clearing ointment obtained in step 3, and concentrated under reduced pressure to a paste with a relative density of 1.15. The paste is vacuum belt-dried and crushed to obtain dry paste powder;
5、向干膏粉加入适量85%的乙醇制成颗粒,干燥得干颗粒;5. Add an appropriate amount of 85% ethanol to the dry paste powder to make granules, and dry them to obtain dry granules;
6、将薄荷脑和步骤2所得的广藿香挥发油用适量乙醇溶解后喷入步骤5所得的干颗粒,混匀,装入胶囊,得到中药组合物胶囊。6. Dissolve the menthol and the patchouli volatile oil obtained in step 2 with an appropriate amount of ethanol and spray them into the dry particles obtained in step 5, mix them, and fill them into capsules to obtain capsules of traditional Chinese medicine composition.
对比实施例1Comparative Example 1
1、按照以下重量比例称取各净选的中药材:连翘200、金银花300、板蓝根200、大黄40、广藿香60、绵马贯众300、红景天100、薄荷脑9、麻黄60、苦杏仁100、鱼腥草200、甘草100、石膏200;1. Weigh the selected Chinese medicinal materials according to the following weight ratios: Forsythia 200, Honeysuckle 300, Isatis root 200, Rhubarb 40, Patchouli 60, Mianma Guanzhong 300, Rhodiola 100, Menthol 9, Ephedra 60 , Bitter Almond 100, Houttuynia Cordata 200, Licorice 100, Gypsum 200;
2、向广藿香加10重量体积比的水,煮沸提取挥发油,提取时间4小时,收集广藿香挥发油,将提取液过滤后得到广藿香清膏备用,残渣弃去;2. Add 10 weight-volume water to the patchouli, extract the volatile oil by boiling, extract the volatile oil for 4 hours, collect the patchouli volatile oil, filter the extract to obtain a patchouli cream for later use, and discard the residue;
3、将连翘、麻黄、鱼腥草和大黄用10重量体积比的90%的乙醇共提2次,第一次2小时,第二次1.5小时,提取液过滤,滤液合并,回收乙醇得到第一清膏备用;3. Extract forsythia, ephedra, houttuynia cordata and rhubarb with 90% ethanol at a ratio of 10 weight by volume for 2 times, the first time is 2 hours, the second time is 1.5 hours, the extract is filtered, the filtrates are combined, and the ethanol is recovered The first clear ointment is reserved;
4、向金银花、石膏、板蓝根、绵马贯众、甘草和红景天加11重量体积比的水煎煮至沸,加入苦杏仁,煎煮2次,第一次1.5小时,第二次1小时,将提取液过滤,将滤液加入步骤2所得的广藿香清膏,浓缩成相对密度为1.15的清膏,加入95%乙醇,边加边搅拌,至醇浓度为70%,室温放置24小时,经板框过滤、滤液回收乙醇至无醇味得到第二清膏,将第二清膏与步骤3所得的第一清膏合并,常压浓缩至相对密度1.20的膏状物,将该膏状物在45-48℃下进行喷雾干燥,得干膏粉;4. Add 11 weight-volume water to honeysuckle, gypsum, Radix isatidis, Mianma Guanzhong, licorice and rhodiola, and boil until boiling, add bitter almonds, decoc 2 times, 1.5 hours for the first time, and 1 for the second time. After hours, filter the extract, add the filtrate to the patchouli cream obtained in step 2, and concentrate it into a clear cream with a relative density of 1.15. Add 95% ethanol and stir while adding until the alcohol concentration is 70%. Place at room temperature for 24 hours. After hours, the second clear ointment is obtained by filtering through the plate and frame and recovering ethanol from the filtrate until there is no alcohol. Combine the second clear ointment with the first clear ointment obtained in step 3, and concentrate to a paste with a relative density of 1.20 under normal pressure. The paste is spray-dried at 45-48°C to obtain dry paste powder;
5、向干膏粉加入适量85%的乙醇制成颗粒,干燥得干颗粒;5. Add an appropriate amount of 85% ethanol to the dry paste powder to make granules, and dry them to obtain dry granules;
6、将薄荷脑和步骤2所得的广藿香挥发油用适量乙醇溶解后喷入步骤5所得的干颗粒,混匀,装入胶囊,得到中药组合物胶囊。6. Dissolve the menthol and the patchouli volatile oil obtained in step 2 with an appropriate amount of ethanol and spray them into the dry particles obtained in step 5, mix them, and fill them into capsules to obtain capsules of traditional Chinese medicine composition.
对比实施例2Comparative Example 2
1、按照以下重量比例称取各净选的中药材:连翘300、金银花200、板蓝根300、大黄60、广藿香100、绵马贯众200、红景天60、薄荷脑5、麻黄100、苦杏仁60、鱼腥草300、甘草60、石膏300;1. Weigh the selected Chinese medicinal materials according to the following weight ratios: Forsythia 300, Honeysuckle 200, Isatis root 300, Rhubarb 60, Patchouli 100, Mianma Guanzhong 200, Rhodiola 60, Menthol 5, Ephedra 100 , Bitter Almond 60, Houttuynia 300, Licorice 60, Gypsum 300;
2、向广藿香加8重量体积比的水,煮沸提取挥发油,提取时间4小时,收集广藿香挥发油,将提取液过滤后得到广藿香清膏备用,残渣弃去;2. Add 8 weight-volume water to the patchouli to extract the volatile oil, extract the volatile oil for 4 hours, collect the patchouli volatile oil, filter the extract to obtain a patchouli cream for later use, and discard the residue;
3、将连翘、麻黄、鱼腥草和大黄用6重量体积比的60%的乙醇共提2次,第一次2小时,第二次1.5小时,提取液过滤,滤液合并,回收乙醇得到第一清膏备用;3. Extract forsythia, ephedra, houttuynia cordata and rhubarb with 6 weight-volume 60% ethanol for 2 times, the first time is 2 hours, the second time is 1.5 hours, the extract is filtered, the filtrates are combined, and the ethanol is recovered The first clear ointment is reserved;
4、向金银花、石膏、板蓝根、绵马贯众、甘草和红景天加7重量体积比的水煎煮至沸,加入苦杏仁,煎煮2次,第一次1.5小时,第二次1小时,将提取液过滤,将滤液加入步骤2所得的广藿香清膏,浓缩成相对密度为1.10的清膏,加入95%乙醇,边加边搅拌,至醇浓度为70%,室温放置24小时,经板框过滤、滤液回收乙醇至无醇味得到第二清膏,将第二清膏与步骤3所得的第一清膏合并,常压浓缩至相对密度1.15的膏状物,将该膏状物在45-48℃下进行喷雾干燥,得干膏粉;4. Add 7 weight-volume water to honeysuckle, gypsum, Radix isatidis, Mianma Guanzhong, licorice and rhodiola, and boil until boiling, add bitter almonds, decoc 2 times, first 1.5 hours, second 1 After hours, filter the extract, add the filtrate to the patchouli cream obtained in step 2, and concentrate it into a cream with a relative density of 1.10. Add 95% ethanol and stir while adding until the alcohol concentration is 70%. Place at room temperature for 24 hours. After hours, filter through the plate and frame and recover the ethanol from the filtrate until there is no alcohol to obtain the second clear paste. Combine the second clear paste with the first clear paste obtained in step 3, and concentrate it to a paste with a relative density of 1.15 under normal pressure. The paste is spray-dried at 45-48°C to obtain dry paste powder;
5、向干膏粉加入适量85%的乙醇制成颗粒,干燥得干颗粒;5. Add an appropriate amount of 85% ethanol to the dry paste powder to make granules, and dry them to obtain dry granules;
6、将薄荷脑和步骤2所得的广藿香挥发油用适量乙醇溶解后喷入步骤5所得的干颗粒,混匀,装入胶囊,得到中药组合物胶囊。6. Dissolve the menthol and the patchouli volatile oil obtained in step 2 with an appropriate amount of ethanol and spray them into the dry particles obtained in step 5, mix them, and fill them into capsules to obtain capsules of traditional Chinese medicine composition.
对比实施例3Comparative Example 3
1、按照以下重量比例称取各净选的中药材:连翘278、金银花294、板蓝根285、大黄55、广藿香95、绵马贯众290、红景天87、薄荷脑8.5、麻黄88、苦杏仁80、鱼腥草284、甘草95、石膏277;1. Weigh the selected Chinese medicinal materials according to the following weight ratio: Forsythia 278, Honeysuckle 294, Isatis root 285, Rhubarb 55, Patchouli 95, Mianma Guanzhong 290, Rhodiola 87, Menthol 8.5, Ephedra 88 , Bitter Almond 80, Houttuynia Cordata 284, Licorice 95, Gypsum 277;
2、向广藿香加9重量体积比的水,煮沸提取挥发油,提取时间4小时,收集广藿香挥发油,将提取液过滤后得到广藿香清膏备用,残渣弃去;2. Add 9 weight-volume water to the patchouli to extract the volatile oil, extract the volatile oil for 4 hours, collect the patchouli volatile oil, filter the extract to obtain a patchouli cream for later use, and discard the residue;
3、将连翘、麻黄、鱼腥草和大黄用6重量体积比的80%的乙醇共提2次,第一次2小时,第二次1.5小时,提取液过滤,滤液合并,回收乙醇得到第一 清膏备用;3. Extract forsythia, ephedra, houttuynia cordata and rhubarb with 6 weight-volume 80% ethanol for 2 times, the first time is 2 hours, the second time is 1.5 hours, the extract is filtered, the filtrates are combined, and the ethanol is recovered The first clear ointment is reserved;
4、向金银花、石膏、板蓝根、绵马贯众、甘草和红景天加10重量体积比的水煎煮至沸,加入苦杏仁,煎煮2次,第一次1.5小时,第二次1小时,将提取液过滤,将滤液加入步骤2所得的广藿香清膏,浓缩成相对密度为1.10的清膏,加入95%乙醇,边加边搅拌,至醇浓度为70%,室温放置24小时,经板框过滤、滤液回收乙醇至无醇味得到第二清膏,将第二清膏与步骤3所得的第一清膏合并,常压浓缩至相对密度1.15的膏状物,将该膏状物在45-48℃下进行喷雾干燥,得干膏粉;4. Add 10 weight-volume water to honeysuckle, gypsum, Radix isatidis, Mianma Guanzhong, licorice and Rhodiola and boil until boiling, add bitter almonds, decoc 2 times, first 1.5 hours, second 1 After hours, filter the extract, add the filtrate to the patchouli cream obtained in step 2, and concentrate it into a cream with a relative density of 1.10. Add 95% ethanol and stir while adding until the alcohol concentration is 70%. Place at room temperature for 24 hours. After hours, filter through the plate and frame and recover the ethanol from the filtrate until there is no alcohol to obtain the second clear paste. Combine the second clear paste with the first clear paste obtained in step 3, and concentrate it to a paste with a relative density of 1.15 under normal pressure. The paste is spray-dried at 45-48°C to obtain dry paste powder;
5、向干膏粉加入适量85%的乙醇制成颗粒,干燥得干颗粒;5. Add an appropriate amount of 85% ethanol to the dry paste powder to make granules, and dry them to obtain dry granules;
6、将薄荷脑和步骤2所得的广藿香挥发油用适量乙醇溶解后喷入步骤5所得的干颗粒,混匀,装入胶囊,得到中药组合物胶囊。6. Dissolve the menthol and the patchouli volatile oil obtained in step 2 with an appropriate amount of ethanol and spray them into the dry particles obtained in step 5, mix them, and fill them into capsules to obtain capsules of traditional Chinese medicine composition.
对比实施例4Comparative Example 4
1、按照以下重量比例称取各净选的中药材:连翘255、金银花255、板蓝根255、大黄51、广藿香85、绵马贯众255、红景天85、薄荷脑7.5、麻黄85、苦杏仁85、鱼腥草255、甘草85、石膏255;1. Weigh the selected Chinese herbal medicines according to the following weight ratios: Forsythia 255, Honeysuckle 255, Isatis root 255, Rhubarb 51, Patchouli 85, Mianma Guanzhong 255, Rhodiola 85, Menthol 7.5, Ephedra 85 , Bitter Almond 85, Houttuynia 255, Licorice 85, Gypsum 255;
2、向广藿香加9重量体积比的水,煮沸提取挥发油,提取时间4小时,收集广藿香挥发油,将提取液过滤后得到广藿香清膏备用,残渣弃去;2. Add 9 weight-volume water to the patchouli to extract the volatile oil, extract the volatile oil for 4 hours, collect the patchouli volatile oil, filter the extract to obtain a patchouli cream for later use, and discard the residue;
3、将连翘、麻黄、鱼腥草和大黄用6重量体积比的80%的乙醇共提2次,第一次2小时,第二次1.5小时,提取液过滤,滤液合并,回收乙醇得到第一清膏备用;3. Extract forsythia, ephedra, houttuynia cordata and rhubarb with 6 weight-volume 80% ethanol for 2 times, the first time is 2 hours, the second time is 1.5 hours, the extract is filtered, the filtrates are combined, and the ethanol is recovered The first clear ointment is reserved;
4、向金银花、石膏、板蓝根、绵马贯众、甘草和红景天加10重量体积比的水煎煮至沸,加入苦杏仁,煎煮2次,第一次1.5小时,第二次1小时,将提取液过滤,将滤液加入步骤2所得的广藿香清膏,浓缩成相对密度为1.10的清膏,加入95%乙醇,边加边搅拌,至醇浓度为70%,室温放置24小时,经板框过滤、滤液回收乙醇至无醇味得到第二清膏,将第二清膏与步骤3所得的第一清膏合并,常压浓缩至相对密度1.15的膏状物,将该膏状物在45-48℃下进行喷雾干燥,得干膏粉;4. Add 10 weight-volume water to honeysuckle, gypsum, Radix isatidis, Mianma Guanzhong, licorice and Rhodiola and boil until boiling, add bitter almonds, decoc 2 times, first 1.5 hours, second 1 After hours, filter the extract, add the filtrate to the patchouli cream obtained in step 2, and concentrate it into a cream with a relative density of 1.10. Add 95% ethanol and stir while adding until the alcohol concentration is 70%. Place at room temperature for 24 hours. After hours, filter through the plate and frame and recover the ethanol from the filtrate until there is no alcohol to obtain the second clear paste. Combine the second clear paste with the first clear paste obtained in step 3, and concentrate it to a paste with a relative density of 1.15 under normal pressure. The paste is spray-dried at 45-48°C to obtain dry paste powder;
5、向干膏粉加入适量85%的乙醇制成颗粒,干燥得干颗粒;5. Add an appropriate amount of 85% ethanol to the dry paste powder to make granules, and dry them to obtain dry granules;
6、将薄荷脑和步骤2所得的广藿香挥发油用适量乙醇溶解后喷入步骤5所得的干颗粒,混匀,装入胶囊,得到中药组合物胶囊。6. Dissolve the menthol and the patchouli volatile oil obtained in step 2 with an appropriate amount of ethanol and spray them into the dry particles obtained in step 5, mix them, and fill them into capsules to obtain capsules of traditional Chinese medicine composition.
含量测定实施例Assay Examples
色谱条件Chromatographic conditions
Waters Acquity UPLC HSS T3(柱长为100mm,内径为2.1mm,粒径为1.8μm)色谱柱,以甲醇-乙腈-0.1%磷酸为流动相,按下表进行梯度洗脱,检测波长为239nm,流速0.3ml/min。Waters Acquity UPLC HSS T3 (column length is 100mm, inner diameter is 2.1mm, particle size is 1.8μm) chromatographic column, using methanol-acetonitrile-0.1% phosphoric acid as mobile phase, gradient elution is performed as follows, detection wavelength is 239nm, The flow rate is 0.3ml/min.
流动相梯度洗脱Mobile phase gradient elution
Figure PCTCN2019083519-appb-000001
Figure PCTCN2019083519-appb-000001
对照品溶液的制备Preparation of reference solution
取盐酸麻黄碱和盐酸伪麻黄碱对照品适量,精密称定,加甲醇-水(含0.092%磷酸、0.04%三乙胺和0.02%二正丁胺)10:90制成每1mL含30μg盐酸麻黄碱和8μg盐酸伪麻黄碱的混合溶液,即得。Take an appropriate amount of ephedrine hydrochloride and pseudoephedrine hydrochloride reference substance, accurately weigh it, add methanol-water (containing 0.092% phosphoric acid, 0.04% triethylamine and 0.02% di-n-butylamine) 10:90 to make 30μg ephedrine hydrochloride per 1mL And 8μg pseudoephedrine hydrochloride mixed solution, that is.
取苦杏仁苷对照品适量,精密称定,加流动相(甲醇-乙腈-0.1%磷酸)制成每1mL含161.85μg的溶液,即得。Take an appropriate amount of amygdalin reference substance, accurately weigh it, and add the mobile phase (methanol-acetonitrile-0.1% phosphoric acid) to make a solution containing 161.85 μg per 1 mL, and get it.
取大黄酚和大黄素对照品适量,精密称定,加甲醇制成每1mL含64μg大黄酚和29μg大黄素的混合对照品溶液,即得。Take an appropriate amount of chrysophanol and emodin reference substance, accurately weigh it, and add methanol to make a mixed reference substance solution containing 64μg chrysophanol and 29μg emodin per 1mL, and get it.
取新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A、4,5-二-O-咖啡酰奎宁酸、槲皮苷、甘草酸铵对照品(甘草酸重量=甘草酸铵重量/1.0207,按此计算 甘草酸的量)适量,精密称定,加50%甲醇制成每1mL含30.86μg新绿原酸、77.55μg绿原酸、33.66μg隐绿原酸、95.52μg异连翘酯苷A、29.75μg4,5-二-O-咖啡酰奎宁酸、22.67μg槲皮苷和42.92μg甘草酸铵的混合溶液,即得(甘草酸重量=甘草酸铵重量/1.0207)。Take neochlorogenic acid, chlorogenic acid, cryptochlorogenic acid, isoforsythoside A, 4,5-di-O-caffeoylquinic acid, quercetin, ammonium glycyrrhizinate reference substance (glycyrrhizic acid weight = licorice Ammonium acid weight/1.0207, calculate the amount of glycyrrhizic acid based on this) appropriate amount, accurately weighed, and add 50% methanol to make 30.86μg neochlorogenic acid, 77.55μg chlorogenic acid, 33.66μg cryptochlorogenic acid, 95.52μg per 1mL A mixed solution of isforsythoside A, 29.75μg 4,5-di-O-caffeoylquinic acid, 22.67μg quercetin and 42.92μg ammonium glycyrrhizinate, namely (glycyrrhizic acid weight = ammonium glycyrrhizinate weight / 1.0207 ).
取连翘苷对照品适量,精密称定,加50%甲醇制成每1mL含6μg的对照品溶液,即得。Take an appropriate amount of forsythin reference substance, accurately weigh it, add 50% methanol to make a reference substance solution containing 6 μg per 1 mL, and get it.
供试品溶液的制备Preparation of test solution
取上述制备实施例1-4和对比实施例1-4制备的中药组合物胶囊的内容物适量,研细,取0.25g,精密称定,置具塞锥形瓶中,精密加入50%甲醇25mL,称定重量,超声处理(功率500W,频率40kHz)30分钟,放冷,再称定重量,用50%的甲醇补足减失的重量,摇匀,滤过,取续滤液,即得。Take an appropriate amount of the contents of the traditional Chinese medicine composition capsules prepared in the above Preparation Example 1-4 and Comparative Example 1-4, grind it into fine pieces, take 0.25g, accurately weigh it, place it in a stoppered conical flask, and accurately add 50% methanol 25mL, weigh it, ultrasonic treatment (power 500W, frequency 40kHz) for 30 minutes, let it cool, then weigh it, use 50% methanol to make up the lost weight, shake well, filter, and take the additional filtrate to get it.
测定法Assay
分别精密吸取各个对照品溶液与供试品溶液各2μL,注入高液相色谱仪,测定,即得。计算各样品中的盐酸麻黄碱、盐酸伪麻黄碱、苦杏仁苷、大黄酚、大黄素、绿原酸、新绿原酸、隐绿原酸、异连翘酯苷A、4,5-二-O-咖啡酰奎宁酸、槲皮苷、甘草酸和连翘苷的含量,见以下各表。Precisely draw 2μL each of each reference solution and test solution, and inject it into a high-performance liquid chromatograph for determination. Calculate the ephedrine hydrochloride, pseudoephedrine hydrochloride, amygdalin, chrysophanol, emodin, chlorogenic acid, neochlorogenic acid, cryptochlorogenic acid, isoforsythiaside A, 4,5-di-O- in each sample The contents of caffeoylquinic acid, quercetin, glycyrrhizin and forsythin are shown in the following tables.
表1盐酸麻黄碱和盐酸伪麻黄碱的总含量Table 1 Total content of ephedrine hydrochloride and pseudoephedrine hydrochloride
Figure PCTCN2019083519-appb-000002
Figure PCTCN2019083519-appb-000002
表2苦杏仁苷含量Table 2 Amygdalin content
Figure PCTCN2019083519-appb-000003
Figure PCTCN2019083519-appb-000003
表3大黄酚和大黄素的含量Table 3 The content of chrysophanol and emodin
Figure PCTCN2019083519-appb-000004
Figure PCTCN2019083519-appb-000004
表4绿原酸、新绿原酸、隐绿原酸、异连翘酯苷A、槲皮苷、4,5-二-O-咖啡酰Table 4 Chlorogenic acid, neochlorogenic acid, cryptochlorogenic acid, isoforsythoside A, quercetin, 4,5-di-O-caffeoyl
Figure PCTCN2019083519-appb-000005
Figure PCTCN2019083519-appb-000005
表5连翘苷含量Table 5 Forsythin content
Figure PCTCN2019083519-appb-000006
Figure PCTCN2019083519-appb-000006
通过表1至表5可知,制备实施例1-4中的盐酸麻黄碱、盐酸伪麻黄碱、苦杏仁苷、大黄酚、大黄素、新绿原酸、绿原酸、隐绿原酸、异连翘酯苷A、4,5-二-O-咖啡酰奎宁酸、槲皮苷、甘草酸和连翘苷的含量相比于对比实施例1-4均有提高。It can be seen from Table 1 to Table 5 that the ephedrine hydrochloride, pseudoephedrine hydrochloride, amygdalin, chrysophanol, emodin, neochlorogenic acid, chlorogenic acid, cryptochlorogenic acid, and isoforsythiae in preparation examples 1-4 The contents of glycoside A, 4,5-di-O-caffeoylquinic acid, quercetin, glycyrrhizin, and forsythin were all increased compared to Comparative Examples 1-4.
活性实施例Active Example
为比较对比实施例的中药组合物与本申请的中药组合物在抗流感、治疗感冒、治疗扁桃体炎的临床疗效,采用对比实施例1和制备实施例1的方法分别获得样品A和样品B,进行如下临床试验。In order to compare the clinical efficacy of the Chinese medicinal composition of the comparative example and the Chinese medicinal composition of this application in anti-flu, treating colds, and treating tonsillitis, the methods of Comparative Example 1 and Preparation Example 1 were used to obtain sample A and sample B, respectively. Perform the following clinical trials.
1临床资料1 clinical data
1.1诊断标准1.1 Diagnostic criteria
参照《中药新药临床研究指导原则·中医新药治疗感冒的临床研究指导原则》中感冒的诊断标准;卫生部《流行性感冒诊断与治疗指南》(卫生部流行性感冒诊断与治疗指南编撰专家组,2011年版,社区医学杂志,2011,9(5):66-74)制定的流行性感冒的诊断标准;普通高等教育“十一五”国家级规划教材《耳鼻咽喉颈外科学》(田勇泉,人民卫生出版社,第7版,2009 年)和《中医耳鼻咽喉科常见病诊疗指南》(中华中医药学会,中国中医药出版社,2012)制定的扁桃体炎的诊断标准。Refer to the "Guiding Principles for Clinical Research of New Chinese Medicines · Guidelines for Clinical Research of New Chinese Medicines for the Treatment of Colds"; the Ministry of Health "Influenza Diagnosis and Treatment Guidelines" (the Ministry of Health's Influenza Diagnosis and Treatment Guidelines Compilation Expert Group, 2011 edition, Community Medicine Journal, 2011, 9(5): 66-74) established the diagnostic criteria for influenza; the national planning textbook "Otorhinolaryngology and Neck Surgery" (Tian Yongquan, People Health Publishing House, 7th Edition, 2009) and "Guidelines for the Diagnosis and Treatment of Common Diseases in Traditional Chinese Medicine Otorhinolaryngology" (Chinese Society of Traditional Chinese Medicine, China Traditional Chinese Medicine Publishing House, 2012).
1.2一般资料1.2 General information
以河北以岭医院门诊就诊的感冒、流行性感冒及扁桃体炎患者为研究对象,采用数字表格法随机分为样品A组和样品B组各84例。Taking cold, influenza and tonsillitis patients in the outpatient clinic of Yiling Hospital of Hebei Province as the research object, they were randomly divided into sample A group and sample B group with 84 cases each by using the digital table method.
样品A组:男54例,女30例;年龄15~63岁,平均年龄37岁。Sample group A: 54 males and 30 females; aged 15-63 years old, with an average age of 37 years.
样品B组:男52例,女32例;年龄13~64岁,平均年龄38岁。Sample group B: 52 males and 32 females; age 13-64 years old, average age 38 years old.
两组性别、年龄、身体状况及病史等资料经统计学处理,差异无显著性意义(P>0.05),具有可比性。The gender, age, physical condition and medical history of the two groups were statistically processed, and the differences were not significant (P>0.05) and were comparable.
2治疗方法2 treatment methods
给予两组患者相应护理,医嘱多饮水。样品A组的患者给予样品A;样品B组的患者给予样品B;两组均连续治疗7天,分别记录两组治疗前后中医证候评分、药物缓解发热作用时间及脓点消失时间并进行比较。The two groups of patients were given corresponding care and the doctor ordered to drink more water. Patients in the sample group A were given sample A; patients in the sample B group were given sample B; both groups were treated for 7 consecutive days. The scores of TCM syndromes, the time of medicine to relieve fever and the disappearance time of pus spots were recorded and compared before and after treatment. .
3观察指标及疗效标准3 Observation indicators and efficacy standards
3.1疗效观测指标3.1 Curative effect observation index
3.1.1中医症候积分3.1.1 TCM syndrome points
分别于治疗前及治疗后7天观察患者症状变化(发热、鼻塞流涕、恶风或恶寒、咽痛等),参照《中药新药临床研究指导原则》(2000年)中的常见症状分级量化表,拟定症候评分,无症状计0分,轻度症状记1分,中度症状记2分,重度症状记3分,详见附表6。Observe the patient’s symptoms before treatment and 7 days after treatment (fever, nasal congestion, runny nose, nausea or chills, sore throat, etc.), referring to the classification and quantification of common symptoms in the "Guiding Principles for Clinical Research on New Chinese Medicines" (2000) Table, the proposed symptom score, 0 points for asymptomatic, 1 point for mild symptoms, 2 points for moderate symptoms, and 3 points for severe symptoms. See Appendix 6 for details.
表6中医症候评分表Table 6 TCM Syndrome Score Sheet
Figure PCTCN2019083519-appb-000007
Figure PCTCN2019083519-appb-000007
3.1.2药物缓解发热作用时间3.1.2 Action time of drugs to relieve fever
记录药物起效时间、解热时间及痊愈时间。起效时间为体温自服药后降低0.5℃所需时间。解热时间为体温自服药后降低至37℃所需时间。痊愈时间为自服药后临床症状完全消失所需时间。Record the onset time, antipyretic time and healing time of the drug. The onset time is the time required for the body temperature to decrease by 0.5°C after taking the medicine. Antipyretic time is the time required for body temperature to drop to 37°C after taking the medicine. The recovery time is the time required for the clinical symptoms to disappear completely after taking the medicine.
3.1.3脓点消失时间3.1.3 Time of pus disappearance
观察两组脓点消失时间并进行比较。Observe and compare the disappearance time of pus spots in the two groups.
3.2疗效评估标准3.2 Efficacy evaluation criteria
参照国家中医药管理局发布的《中医病证诊断疗效标准》(国家中医药管理局·中医病症诊断疗效标准,北京:中国医药科技出版社,2012.11)和《中药新药临床研究指导原则》(中华人民共和国卫生部·中药新药临床研究指导原则(第一辑),北京:中国医药科技出版社,1993.11)。Refer to the "Diagnosis and Efficacy Standards for Diseases and Symptoms of Traditional Chinese Medicine" (National Administration of Traditional Chinese Medicine·Diagnosis and Efficacy Standards for Diseases of Traditional Chinese Medicine, Beijing: China Medical Science and Technology Press, 2012.11) and "Guiding Principles for Clinical Research of New Chinese Medicines" (Zhonghua Ministry of Health of the People's Republic of China. Guidelines for Clinical Research of New Chinese Medicines (First Series), Beijing: China Medical Science and Technology Press, 1993.11).
痊愈:症状消失,体温正常,主症积分减少≥95%;显效:症状明显改善,体温正常,70%≤主症积分减少<95%;有效:症状稍好转,体温38℃以下,30%≤主症积分减少<70%;无效:症状无明显改善或加重,主症积分减少<30%。总有效率=(痊愈例数+显效例数+有效例数)/n×100%。Healed: symptoms disappear, body temperature is normal, main symptom score is reduced by ≥95%; markedly effective: symptoms are significantly improved, body temperature is normal, 70%≤main symptom score reduction is less than 95%; effective: symptoms are slightly improved, body temperature is below 38°C, 30%≤ The main symptom score decreased by <70%; invalid: the symptoms were not significantly improved or worsened, the main symptom score decreased by <30%. Total effective rate=(number of cured cases+number of markedly effective cases+number of effective cases)/n×100%.
3.3治疗结果3.3 Treatment results
3.3.1两组患者治疗前后症候积分比较
Figure PCTCN2019083519-appb-000008
3.3.1 Comparison of symptom scores before and after treatment between the two groups
Figure PCTCN2019083519-appb-000008
表7Table 7
Figure PCTCN2019083519-appb-000009
Figure PCTCN2019083519-appb-000009
在治疗前后症状积分改善方面,样品B组相较样品A组更具临床优势,差异具有统计学意义(P<0.05)。In terms of symptom score improvement before and after treatment, the sample B group has more clinical advantages than the sample A group, and the difference is statistically significant (P<0.05).
3.3.2两组药物缓解发热时间比较
Figure PCTCN2019083519-appb-000010
3.3.2 Comparison of the time for the two groups of drugs to relieve fever
Figure PCTCN2019083519-appb-000010
表8Table 8
Figure PCTCN2019083519-appb-000011
Figure PCTCN2019083519-appb-000011
在药物作用起效时间方面,样品B组与样品A组相比,差异无统计学意义(P>0.05)。In terms of onset time of drug action, there was no statistically significant difference between sample B group and sample A group (P>0.05).
3.3.3两组脓点消失时间
Figure PCTCN2019083519-appb-000012
3.3.3 The disappearance time of pus spots in the two groups
Figure PCTCN2019083519-appb-000012
表9Table 9
Figure PCTCN2019083519-appb-000013
Figure PCTCN2019083519-appb-000013
样品B组脓点消失的时间短于样品A组,差异具有统计学意义(P<0.05)。The disappearance of pus spots in sample B group was shorter than that in sample A, and the difference was statistically significant (P<0.05).
3.3.4两组患者临床疗效比较(例数)3.3.4 Comparison of clinical efficacy between the two groups of patients (number of cases)
表10Table 10
Figure PCTCN2019083519-appb-000014
Figure PCTCN2019083519-appb-000014
样品B组总有效率明显优于样品A组,差异有统计学意义(P<0.05)。The total effective rate of sample B group was significantly better than that of sample A group, and the difference was statistically significant (P<0.05).
3.3.5安全性评价3.3.5 Safety evaluation
本临床观察中,样品A组和样品B组的患者均未出现严重的不良反应及过敏症状;治疗前后,患者一般体格检查、血尿常规及肝肾功能均在正常范围内。In this clinical observation, the patients in the sample A group and the sample B group did not have serious adverse reactions and allergic symptoms; before and after treatment, the patients' general physical examination, blood and urine routine, and liver and kidney functions were all within the normal range.
4结论4 Conclusion
观察表明,采用制备实施例1的制备方法获得的样品B的抗流感、治疗感冒、扁桃体炎疗效确切,与对比实施例1获得的样品A相比较临床治疗效果更好,且无不良反应发生。Observation shows that the sample B obtained by the preparation method of Preparation Example 1 has a definite anti-flu, cold, and tonsillitis curative effect. Compared with the sample A obtained in Comparative Example 1, the clinical treatment effect is better, and no adverse reactions occur.

Claims (10)

  1. 中药组合物,其由以下质量份的中药原料制成:连翘200-300、麻黄60-100、大黄40-60、鱼腥草200-300、金银花200-300、板蓝根200-300、藿香60-100、绵马贯众200-300、红景天60-100、薄荷脑5-9、苦杏仁60-100、甘草60-100、石膏200-300;Chinese medicine composition, which is made of Chinese medicine raw materials of the following parts by mass: Forsythia 200-300, Ephedra 60-100, Rhubarb 40-60, Houttuynia 200-300, Honeysuckle 200-300, Radix Isatidis 200-300, Huoxiang 60-100, Mianma Guanzhong 200-300, Rhodiola 60-100, Menthol 5-9, Bitter Almond 60-100, Licorice 60-100, Gypsum 200-300;
    所述中药组合物包含以下含量的成分:The traditional Chinese medicine composition contains the following ingredients:
    0.4-0.9mg/g的盐酸麻黄碱和盐酸伪麻黄碱、2.2-4.3mg/g的苦杏仁苷、0.25-0.75mg/g的大黄酚、0.15-0.40mg/g的大黄素、2.4-5.4mg/g的绿原酸、1.4-2.7mg/g的新绿原酸、1.6-3.4mg/g的隐绿原酸、2.0-5.5mg/g的异连翘酯苷A、1.65-2.90mg/g的4,5-二-O-咖啡酰奎宁酸、2.7-3.8mg/g的槲皮苷、1.4-2.9mg/g的甘草酸和2.5-3.4mg/g的连翘苷。0.4-0.9mg/g ephedrine hydrochloride and pseudoephedrine hydrochloride, 2.2-4.3mg/g amygdalin, 0.25-0.75mg/g chrysophanol, 0.15-0.40mg/g emodin, 2.4-5.4mg/ g of chlorogenic acid, 1.4-2.7mg/g of neochlorogenic acid, 1.6-3.4mg/g of cryptochlorogenic acid, 2.0-5.5mg/g of isoforsythoside A, 1.65-2.90mg/g 4,5-Di-O-caffeoylquinic acid, quercetin at 2.7-3.8mg/g, glycyrrhizin at 1.4-2.9mg/g and forsythin at 2.5-3.4mg/g.
  2. 如权利要求1所述的中药组合物,其中所述中药组合物包含以下含量的成分:4.0-5.4mg/g的绿原酸、2.0-2.7mg/g的新绿原酸、2.5-3.4mg/g的隐绿原酸、3.5-5.5mg/g的异连翘酯苷A、2.0-2.90mg/g的4,5-二-O-咖啡酰奎宁酸、3.0-3.8mg/g的槲皮苷和2.5-2.9mg/g的甘草酸。The traditional Chinese medicine composition according to claim 1, wherein the traditional Chinese medicine composition contains the following ingredients: 4.0-5.4 mg/g chlorogenic acid, 2.0-2.7 mg/g neochlorogenic acid, 2.5-3.4 mg/g g of cryptochlorogenic acid, 3.5-5.5mg/g of isoforsythoside A, 2.0-2.90mg/g of 4,5-di-O-caffeoylquinic acid, 3.0-3.8mg/g of quercetin Cortin and 2.5-2.9mg/g glycyrrhizic acid.
  3. 如权利要求1或2所述的中药组合物,其中所述麻黄为炙麻黄,所述苦杏仁为炒苦杏仁,所述藿香为广藿香。The traditional Chinese medicine composition according to claim 1 or 2, wherein the ephedra ephedra is roasted ephedra, the bitter almond is fried bitter almond, and the huoxiang is patchouli.
  4. 如权利要求1所述的中药组合物,其中所述中药组合物通过如下方法制备:The traditional Chinese medicine composition according to claim 1, wherein the traditional Chinese medicine composition is prepared by the following method:
    按照上述质量比称取所述中药原料;Weigh the raw materials of Chinese medicine according to the above-mentioned mass ratio;
    将藿香用8-10重量体积比的水提取2-4小时,获得藿香挥发油和藿香清膏;Extract Huoxiang with 8-10 weight-volume water for 2-4 hours to obtain Huoxiang volatile oil and Huoxiang cream;
    将连翘、麻黄、鱼腥草和大黄一并用6-10重量体积比的50-90%的乙醇提取,回收乙醇得到第一清膏;Extract forsythia, ephedra, houttuynia cordata and rhubarb together with 50-90% ethanol at a weight-volume ratio of 6-10, and recover the ethanol to obtain the first clear ointment;
    将金银花、石膏、板蓝根、绵马贯众、甘草和红景天一并用7-11重量体积比的水煮沸,加入苦杏仁,煎煮1-4小时,将获得的提取液与所述藿香清膏混合并将所得的混合物浓缩成清膏,向所述清膏加入95%的乙醇直至乙醇浓度为60-80%,放置12-24小时,经陶瓷膜过滤获得滤液,回收乙醇得到第二清膏;The honeysuckle, gypsum, Radix isatidis, Mianma Guanzhong, licorice and Rhodiola are boiled together with 7-11 weight-volume water, add bitter almonds, decoct for 1-4 hours, and combine the obtained extract with the Agastache Mix the clear ointment and concentrate the resulting mixture into a clear ointment, add 95% ethanol to the clear ointment until the ethanol concentration is 60-80%, leave it for 12-24 hours, filter through a ceramic membrane to obtain the filtrate, and recover the ethanol to obtain the second Clear cream
    将所述第二清膏与所述第一提清膏混合,将混合物减压浓缩得到相对密度1.15-1.20的膏状物,将所述膏状物进行真空带式干燥并粉碎得到干膏粉,向 所述干膏粉加入薄荷脑和所述藿香挥发油从而获得所述中药组合物。The second clearing paste is mixed with the first clearing paste, the mixture is concentrated under reduced pressure to obtain a paste with a relative density of 1.15 to 1.20, and the paste is vacuum-belt dried and crushed to obtain a dry paste powder , Adding menthol and the volatile oil of Huoxiang to the dry powder to obtain the traditional Chinese medicine composition.
  5. 如权利要求4所述中药组合物,其中向所述干膏粉加入85%乙醇,制成颗粒,干燥得干颗粒;向所述干颗粒加入所述薄荷脑、所述藿香挥发油,混匀后装入胶囊,得到中药组合物胶囊剂。The traditional Chinese medicine composition according to claim 4, wherein 85% ethanol is added to the dry ointment powder to form granules, which are dried to obtain dry granules; the menthol and the Huoxiang volatile oil are added to the dry granules and mixed Then, it is filled into capsules to obtain traditional Chinese medicine composition capsules.
  6. 如权利要求4所述的中药组合物,其中将连翘、麻黄、鱼腥草和大黄一并用6-10重量体积比的70%的乙醇提取1-2次,每次1-2小时。The traditional Chinese medicine composition according to claim 4, wherein the forsythia, ephedra, houttuynia cordata and rhubarb are extracted together with 6-10 weight-volume 70% ethanol for 1-2 times, each for 1-2 hours.
  7. 如权利要求4所述的中药组合物,其中将金银花、石膏、板蓝根、绵马贯众、甘草和红景天一并用7-11重量体积比的水煮沸,加入苦杏仁,煎煮1-2次,每次1-2小时,将获得的提取液与所述藿香清膏混合并将所得的混合物浓缩成相对密度为1.10-1.15的清膏。The traditional Chinese medicine composition according to claim 4, wherein the honeysuckle, gypsum, Radix isatidis, Mianma Guanzhong, licorice and Rhodiola are boiled together with water at a weight-volume ratio of 7-11, bitter almonds are added, and decocted for 1-2 Seconds, for 1-2 hours each time, mix the obtained extract with the Huoxiang clear ointment and concentrate the resulting mixture into a clear ointment with a relative density of 1.10-1.15.
  8. 如权利要求4所述中药组合物,其中向所述清膏加入95%的乙醇直至乙醇浓度为70%,放置12-24小时。The traditional Chinese medicine composition according to claim 4, wherein 95% ethanol is added to the clear ointment until the ethanol concentration is 70%, and it is left for 12-24 hours.
  9. 权利要求1-8中任一项所述的中药组合物在制备用于治疗感冒和上呼吸道感染的药物中的用途。Use of the Chinese medicinal composition of any one of claims 1-8 in the preparation of a medicine for the treatment of colds and upper respiratory tract infections.
  10. 如权利要求9所述的用途,其中所述感冒为流行性感冒,所述上呼吸道感染为扁桃体炎症。The use according to claim 9, wherein the common cold is influenza, and the upper respiratory tract infection is tonsil inflammation.
PCT/CN2019/083519 2019-04-19 2019-04-19 Traditional chinese medicine composition and use thereof WO2020211088A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/CN2019/083519 WO2020211088A1 (en) 2019-04-19 2019-04-19 Traditional chinese medicine composition and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2019/083519 WO2020211088A1 (en) 2019-04-19 2019-04-19 Traditional chinese medicine composition and use thereof

Publications (1)

Publication Number Publication Date
WO2020211088A1 true WO2020211088A1 (en) 2020-10-22

Family

ID=72836997

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2019/083519 WO2020211088A1 (en) 2019-04-19 2019-04-19 Traditional chinese medicine composition and use thereof

Country Status (1)

Country Link
WO (1) WO2020211088A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113648378A (en) * 2021-06-25 2021-11-16 浙江省立同德医院 Traditional Chinese medicine compound for treating early stage neocoronary pneumonia and application of traditional Chinese medicine compound for treating respiratory tract infection
CN117530951A (en) * 2024-01-09 2024-02-09 中国中医科学院中药研究所 Composition for treating cold and preparation method and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101450137A (en) * 2007-11-30 2009-06-10 河北以岭医药研究院有限公司 Preparation method of anti-virus traditional Chinese medicine
CN101683424A (en) * 2008-09-26 2010-03-31 北京以岭药业有限公司 Application of Chinese medicine composition in preparation of medicament for treating tonsillitis
CN101797299A (en) * 2009-02-05 2010-08-11 北京以岭药业有限公司 Refining method of traditional Chinese medicine composition water extract liquid containing fructus forsythiae

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101450137A (en) * 2007-11-30 2009-06-10 河北以岭医药研究院有限公司 Preparation method of anti-virus traditional Chinese medicine
CN101683424A (en) * 2008-09-26 2010-03-31 北京以岭药业有限公司 Application of Chinese medicine composition in preparation of medicament for treating tonsillitis
CN101797299A (en) * 2009-02-05 2010-08-11 北京以岭药业有限公司 Refining method of traditional Chinese medicine composition water extract liquid containing fructus forsythiae

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BI, DAN ET AL.: "Content Determination of Amygdalin in the Lianhua Qingwen Capsule by HPLC", CHINA PHARMACY, vol. 27, no. 21, 30 July 2016 (2016-07-30), DOI: 20191213103910Y *
CHEN, YUPENG ET AL.: "Study on UPLC Fingerprints of Lianhua Qingwen Capsules", CHINESE JOURNAL OF INFORMATION ON TRADITIONAL CHINESE MEDICINE, vol. 24, no. 12, 15 December 2017 (2017-12-15), DOI: 20191213104027Y *
QIN, QINGFANG: "Determination of Chlorogenic Acid, Forsythin, Rhein, Emodin and Chrysophanol in Lianhuan Qingwen Capsules by HPLC", CHINESE JOURNAL OF MODERN APPLIED PHARMACY, vol. 31, no. 02, 28 February 2014 (2014-02-28), DOI: 20191213104139Y *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113648378A (en) * 2021-06-25 2021-11-16 浙江省立同德医院 Traditional Chinese medicine compound for treating early stage neocoronary pneumonia and application of traditional Chinese medicine compound for treating respiratory tract infection
CN113648378B (en) * 2021-06-25 2022-04-22 浙江省立同德医院 Traditional Chinese medicine compound for treating early stage neocoronary pneumonia and application of traditional Chinese medicine compound for treating respiratory tract infection
CN117530951A (en) * 2024-01-09 2024-02-09 中国中医科学院中药研究所 Composition for treating cold and preparation method and application thereof
CN117530951B (en) * 2024-01-09 2024-05-03 中国中医科学院中药研究所 Composition for treating cold and preparation method and application thereof

Similar Documents

Publication Publication Date Title
US10105408B2 (en) Traditional Chinese medicine composition and preparation method and use thereof
WO2022036779A1 (en) Huashibaidu granule, preparation method therefor and anti-viral drug
Zheng et al. Ephedrae herba: A comprehensive review of its traditional uses, phytochemistry, pharmacology, and toxicology
CN103386022B (en) Chinese medicine composition for treating tuberculous pleurisy
EP3821902B1 (en) Traditional chinese medicine composition, traditional chinese medicine compound preparation and preparation method and use thereof
WO2020211088A1 (en) Traditional chinese medicine composition and use thereof
CN103341092B (en) Preparation method of powder for treating atrophic vaginitis
CN104815318A (en) Traditional Chinese medicine preparation for treating gout
CN103301353B (en) Pharmaceutical composition for treating atrophic vaginitis
CN103285284B (en) Medical composition for treating senile vaginitis
CN104337989A (en) Traditional Chinese medicine composition containing centipeda minima and frankincense for treating gout
CN103330867B (en) Preparation method of powder for treating senile vaginitis
CN103599379B (en) Traditional Chinese medicine for treatment of liver and kidney deficient type chronic osteomyelitis and its preparation method
CN105250968A (en) Traditional Chinese medicine preparation for treating asthma
CN105796620A (en) New applications of radix notoginseng and radix notoginseng extract to preparation of medicines for treating psoriasis
CN105031380A (en) Drug for oral local anesthesia of pregnant woman and preparation method thereof
CN104887950A (en) Mastitis treatment traditional Chinese medicine compound
CN103920010A (en) Medicinal composition with bleeding-stopping, pain-relieving and inflammation-diminishing effects, preparation method and application thereof
CN112138105B (en) Traditional Chinese medicine composition for treating bronchiectasis lung-spleen qi deficiency and phlegm-damp lung blocking syndrome and application thereof
US11944660B1 (en) Topical traditional Chinese medicine (TCM) composition and topical preparation for cervical disease, and preparation methods thereof
CN111249421B (en) Traditional Chinese medicine preparation for treating initial damp-heat exogenous fever as well as preparation method and application thereof
CN105943700A (en) Traditional Chinese medicine composition capable of tonifying kidney and relieving paralysis and preparation method and application thereof
KR20210121602A (en) Compositions containing Cinnamomi ramulus, Atractylodis rhizoma, Angelica gigas and Zingiberis Rhizoma extracts for the Improvement of Allergic Rhinitis and Manufacturing Method Thereof
CN104707124A (en) Traditional Chinese medicine preparation for treating chronic endometritis
CN104338086A (en) Chinese medicinal enema for treating chronic endometritis and preparation method thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19924752

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19924752

Country of ref document: EP

Kind code of ref document: A1